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Acute pancreatitis is defined as a process involving inflammation of pancreas, the 
surrounding tissues as well as distant organs 
(1).
 Incidence of acute pancreatitis differ in 
different parts of the world, possibly due to the differnce in the consumption of alcohol in 
different places as well as difference in the incidence of gall stones in different parts of world.  
(2)
. Previous studies reported the occurence of acute pancreatitis ranging from  4.9 to 35 per  1 
lakh  populations 
(3)
.  Severe disease was reported in about  20% of individuals  and may be 
associated with mortality close to 20% 
(4)
. 
 
There are varied aetiologies for acute pancreatitis. In one study Steer M L et al, found that in 
45 percent of cases, cholelithiasis was the cause followed by ethanol in 35 percent ,rest in 
10%. In about 10%, a specific cause could not be found and  was grouped under idiopathic
(5) 
. 
In India, the aetiological spectrum of mild pancreatitis included the following: alcoholism in 
41.1%, gallstones in 23.5%, trauma in 17.6%, idiopathic in 11.7% and post-endoscopic 
retrograde cholangiopancreatography in 5.8%. 
(6).
 
 
Acute pancreatitis patients, usually present with pain abdomen and vomiting. Pain typically 
starts in epigastrium and may be radiating to the back also. Abdominal examination may 
reveal tenderness in the epigastrium. In mild cases, usually there will be an uneventful 
recovery and may require only few days of admission in hospital. In severe cases, pain may 
be severe with increase in heart rate, tachypnoea, decreased urine output and hypotension. 
There can be various signs on abdominal examination like cullens and Gray Turners signs. In 
severe cases death also can occur 
(7)
. Such patients can be grouped as severe acute pancreatitis 
when they present with /develop organ failure and or with local complications such as fluid 
collections,  necrosis, abscess, or pseudocyst 
(1)
. 
.  
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It is becoming clear that some combination of genetic mutation polymorphisms provides 
predisposition for severity of the “cytokine storm” following any insult that causes acute 
inflammation. In acute pancreatitis of any aetiology (e.g., alcohol, metabolic derangement, 
physiologic stress to acinar cells), this genetic polymorphic predisposition sets the stage for 
pancreatitis. Recently Heat Shock Protein 70-2 (HSP 70-2) gene has also been associated 
with pancreatic diseases, and so far various studies have shown conflicting results. So a 
definite role of this genetic polymorphism has not yet been confirmed in this disease 
(7).
 
 
The  Heat shock proteins (HSPs)  act as  chaperones which is meant for cell protection from 
injury causing stimuli. In that way, there abnormal  expression can lead to multiple diseases 
including various maignancies. There were previous studies which showed protective 
function of HSP 70 agnaist cell injuries and acinar cell necrosis of pancreas in animal models 
using  knock-out and transgenic approach, as well as using  standard  methods of heat shock 
protein 70 (HSP70) induction such as thermal stress and  arsenite administration
(8) 
. 
 
There are three members in HSP 70 gene family which was mapped and studied in detail in humans. 
They include HSP 70-1, HSP 70-2, and HSP 70-HOM, of which HSP 70-2 encodes the major heat 
inducible HSP70. Previous studies by Milner et al. identified polymorphism in HSP 70 gene,  
polymorphic A to G transition PstI site at position 1267 in  HSP 70-2 coding regions
(9)
. Those who 
are  homozygous for this specific  HSP 70-2 G allele was shown to have  reduced  HSP70-2 mRNA 
expression
 (10)
,  and it was also shown that this  HSP70-2 –1267 A/G is associated with increased risk 
for various diseases and its poor outcomes. It was also shown that those having the above mentioned 
HSP 70-2 G alleles are at risk for developing acute severe pancreatitis 
(11)
. 
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HSP70 is also involved in the innate immune and inflammatory response and certain 
genotypes of HSP70 are associated with higher cytokine output in response to any 
inflammatory stimulus. So assessment of genotype may turn as an important tool for 
predicting prognosis and severity of diseases and for predicting the course of acute 
pancreatitis. Hence assessment of genotype may be used as an important tool to guide 
treatment and to identify population at risk for severe acute pancreatitis. 
 
We proposed that polymorphisms in the Heat Shock Protein 70 gene may play a significant 
role in determining whether the illness manifests as a mild acute pancreatitis or as a severe 
acute pancreatitis, i.e. it may have a disease-modifying effect. 
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AIM 
 
To determine whether there is any association between Heat Shock Protein 70 gene 
polymorphisms and severity of illness and hospital outcomes in patients with acute 
pancreatitis admitted to a tertiary care hospital. 
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Definition 
Acute pancreatitis is defined as a process involving inflammation of pancreas, the 
surrounding tissues as well as distant organs
(1)
.  It can be caused by a variety of conditions 
and can lead to mild acute pancreatitis which is self limiting to severe life-threatening illness. 
 
In 85% of cases with acute pancreatitis,  it can be benign . In the rest 15 % of cases it can turn 
out to be sever, life threatening which requires admission in  intensive care units and 
requiring mechanical ventillaton, dialysis and ionotropic supports. In acute pancreatitis,  there 
is acute inflammation in pancreas with premature activation of pancreatic enzymes. In these 
cases there is pancreatic parenchymal destruction with activation of coagulation, kinin, 
complement and fibrinolytic cascades with increased release of cytokines and reactive oxygen 
metabolites. This in turn can leads to hypotension, respiratory and renal failures requiring 
dialysis and ventillatory supports. 
(12)
.  
 
Incidence 
The reported annual incidence of acute pancreatitis has ranged from 4.9 to 35 per 100,000 
populations
(3)
. Recent increase in the incidence of acute  pancreatitis was noted in many 
countries including Finland, England, Scotland and Germany. There was a recent increase in 
the incidence of acute pancreatitis to 31.8 per 1 lakh in 1985 from 9.4 per 1 lakh in 1968. 
Similar trend was noted in other countries like England and Denmark. This phenomenon was 
explained by the recent increased alcohol intake by the people from these countries as well as 
by the advancement in field of diagnostic imaging modalities 
(13) 
. 
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Aetiologies 
The aetiologies of acute pancreatitis were due to alcoholism in 35.5%, gallstones in 22%, 
trauma in 20%, idiopathic in 13.3% and ERCP 8.8% in one study from Eastern India
(14)
.  In 
one study from central India, the various causes attributed for the development of acute 
pancreatitis were gallstones in 48%, alcohol in 28%,  and others in 24% of the patients 
(15).
  In 
one study from Germany the reported incidences were cholelithiasis in 45% of cases, alcohol 
as the etiology in 35%,  others in 10%  and idiopathic in 10%
(16) 
. 
 
Physiology of pancreatic secretion 
 With stimulation by secretin the daily out put from the pancreas was found to be  1500 - 
2000 ml  of pancreatic fluid fluid and about  150 - 200 mmol  HCO3.  Lipolytic, amylolytic 
and proteolytic enzymes were also secreted by the pancreas  upon  cholinergic stimulation. 
Enzymes for the proteolysis is secreted in a precursor inactive  form. This has to be activated 
by trypsin.  Trypsin is an activated form of enzyme which is produced by the conversion from 
inactive form, the  trypsinogen with the help of enterokinase, an enzyme secreted from the 
mucosa of duodenum. Other proteolytic enzymes like chymotrypsinogen, proelastase, 
procarboxypeptidases and lipolytic and amylolytic enzymes are converted to their active form 
with the help of trypsin.  
 
These enzyme precursors are stored in the zymogen granules. Also there are various 
antitrypsins like  pancreatic secretory trypsin inhibitor, α1-antitrypsin, α2-macroglobulin . 
These above mechanisms protect the pancreas from the enzymatic digestion. When these 
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mechanisms fails then there will be premature activation of pancreatic proenzymes and there 
by leading to pancreatic parenchymal damage .  
 
Pathogenesis of Acute Pancreatitis 
The initial insult of these pancreatic premature activation of enzyme precursors is an abrupt 
increase in the calcium levels in the cytosol. This can lead to premature activation of these 
enzyme precursors
(17)
. This in turn leads to pancreatic parenchymal destruction with 
activation of coagulation, kinin, complement and fibrinolytic  cascades with increased release 
of cytokines and reactive oxygen metabolites. These results in a massive release in the 
inflammatory cytokines like  TNF-α, IL-1, IL-6, IL-8, platelet-activating factor along with  
reactive oxygen metabolites. The massive inflammatory response resulting from the above 
changes results in the systemic manifestations of acute pancreatitis. This in turn can leads to 
increased capillary permeability, hypotension, respiratory and renal failures requiring dialysis 
and ventillatory supports.   
 
Role of Pancreatic enzymes in the genesis of Acute Pancreatitis 
The raised intraductal pressure inside  the pancreatic duct as a result of obstruction in the 
pancreatic duct due to stone, edema or spasm of the sphincter of oddi is termed as pancreatic 
duct hypertension. This can results in small pancreatic ductal rupture thereby causing  
extravasations of pancreatic enzymes into the parenchyma,  leading to pancreatic injury . 
 
 
Duodenopancreatic reflux can result in reflux entry of enterokinase into the pancreas from the 
duodenal lumen which can result in formation of trypsin, the activated form of enzyme which 
is produced from the inactive form, the trypsinogen. This reflux entry happens due to the 
sphincter incompetency secondary to the effect of alcohol, stone passage or result of 
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procedure / surgery. Other proteolytic enzymes like chymotrypsinogen, proelastase, 
procarboxypeptidases and lipolytic and amylolytic enzymes are converted to their active form 
with the help of this prematurely activated trypsin. This in turn leads to the deustruction of 
cell menbranes, edema and further pancreatic parenchymal damage. 
 
Decreased apical exocytosis of pancreatic zymogens: There is decreased secretion from the 
apical side of zymogen granules in cases with acute pancreatitis where as the production 
inside the cell of these granules remains normal. As a result there is accumulation of these 
zymogens inside pancreatic cell. The proposed theory is that, these zymogen granules fuses 
with the membrane of lysozymes inside the cell,  followed by activation of the trypsinogen by 
the cathepsin B, which leads to increased production of active trypsin thereby resulting in  
activation of other precursor enzymes and leading to further pancreatic parenchymal damage. 
Hypersecretion : One of the  rare causes  for acute pancreatitis is the hyper secretion of 
pancreatic enzymes. This happen when there is increased muscarinic stimulation, which can 
occur in association with either poisioning with organophosphates or with scorpion 
enveommation
(12)
. 
 
Role of calcium  
When there is some obstruction to the pancreatic duct, the pancreatic exocrine part changes 
its pattern to a calcium signalling pattern. It will result in premature activation of the 
pancreatic enzymes and there by leading to acute pancreatitis
11)
. Cholecystokinin and 
acetylcholine generates the calcium signal. The cholecystokinin can also stimulate the 
mitochondria. Usually the local cytosolic calcium will act only for a short time and the 
sustained elevated calcium level secondary to toxic cholecystokinin level may be the culprit 
behind the inflammatory states in acute pancreatitis. This toxic levels is also responsible for 
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the formation of  to post-exocytic endocytic vaculoe formation. The pancreatic enzyme got 
activated  in these vacuoles.  
In those with alcohol related pancreatitis , the premature activation of trypsinogen can be 
explained through a calcium dependent mechanism. This happens through the non oxidative 
metabolites such as fatty acids ethyl esters  and fatty acids itself
(12)
.   Following activation of 
trypsinogen to trypsin, the rest of the enzymes also got activated leading to the inflammatory 
cascade in acute pancreatitis .  
 
The main pathogenic mechanisms underlying an episode of acute pancreatitis classically  
involving  the following acinar responses : first one is the accumulation of the vacuoles and 
the trypsinogen activation. Following the  activation of the trypsinogen by the cathepsin B, 
which leads to increased production of active trypsin, there is   activation of other precursor 
enzymes and leading to further pancreatic parenchymal damage.  
 
The pathologically activated trypsin in the acinar cell can be degraded by the pancreatic 
zymogens, chymotrypsin C.  The inactivating mutations in chymotrypsin C is also suggested 
as one of the cause that can increase the risk for  chronic pancreatitis, mainly  in those with 
increased alcohol consumption.  
 
Acute pancreatitis is a dynamic disease with involvement of multiple systems, including the 
cardiovascular system, renal system, respiratory system, necrosis and   infarction of the 
pancreas, and translocation of bacteria from gut as a resulting from gut injury. Vascular leak 
syndrome, which develops in cases with severe pancreatitis is responsible for the 
hemoconcentration, respiratory failures,  renal failures and hypotension. Some of the 
autocrine peptides like angiopoietin 1 and 2 are responsible for increasing and decreasing the 
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endothelial permeability respectively. So the severity of the pancreatitis and persistent organ 
failure is related to the serum angiopoietin-2 levels. So organ failure can be predicted by an 
admission angiopoietin -2 levels. 
 
Role of Genetic Factors in Pancreatitis 
One of the rare forms of recurrent acute and chronic pancreatitis is the Hereditary pancreatitis 
(HP). The gene responsible for this was  mapped to chromosome 7q35  using genome-wide 
genetic linkage analysis
(18)
. Later further gene sequencing of 7q35 chromosome region 
revealed a strong relation  of c.365G > A (p.R122 H) mutation of the PRSS1 gene which 
encodes cationic trypsinogen with HP.  This mutation results in raised  autocatalytic 
conversion of trypsinogen to the active trypsin and there by  causing    premature activation of 
intrapancreatic trypsinogen  in vivo. 
Patients who are homozygous for  SPINK1 N34S mutation are classicaly presents with 
features suggestive of  chronic pancreatitis in early childhood. The exact mechanism 
underlying how this mutation leads to chronic pancreatitis is still un known. Some speculates 
that the reason behind, N34S being associated with decreased expression of SPINK1  is due to 
to the haplotypes and intronic mutations associated with the N34S 
(19)
. 
 
It was found in many studies that 30% of idiopathic chronic pancreatitis is associated with 
CFTR mutations.  Mutations in CFTR are associated with high risk for chronic pancreatitis 
especially in those who are having  two or more heterozygous mutations or one mutation in 
CFTR   accompanied by mutations of PRSS1 and SPINK1 
(20)
. 
 
Systemic inflammation 
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Local injury in the setting of acute pancreatitis may proceed to a systemic inflammatory 
response syndrome (SIRS).  SIRS is defined by 2 or more of the following criteria:  pulse rate 
greater than 90 / min, respiratory rate above 20 per min or an arterial partial pressure of 
carbondioxide (PaCO2 ) of less than 32 mm Hg; temperature higher than 38degree C or less 
than 36 degree C;  white cell count greater than 12,000 or less than 4000 cells / mm3. 
 
In this acute pancreatitis setting, cytokine cascades  activated by the pancreatic inflammation  
manifest clinically as the systemic inflammatory response syndrome (SIRS) and  if the SIRS 
is persisting there is high risk for  multiple organ dysfunction syndrome and even mortality. 
So presence of SIRS can be taken as an  indicator of disease severity in cases with acute 
pancreatitis. In acute severe pancreatitis, there is an interplay between the pro- and anti-
inflammatory response of cytokines  in the cells and this will be present in the body for some 
time.   
 
The neutrophils which are activated by cytokines infiltrates the  organs like  the liver, lung 
and GIT. The distant organ damage in severe pancreatitis can be explained by the effect of 
proteolytic enzymes that is releasing from neutrophils during the episode.  This leads to  
injury of these vital organs and resulting in multiple  vital organs dysfunction distant from the 
pancreas. The cytokines which are responsible for these injuries include TNF -alpha, 
interleukin- 1 (IL-1), interleukin-6 (IL-6) and interleukin-8 
(21)
. Apart from this  
complications in both sepsis and severe acute pancreatitis is mediated by  endotoxins and 
other inflammatory mediators such as platelet activating factor and phospholipase A2.  
Role of Genetic Polymorphisms In Systemic Inflammation  
Heat Shock Proteins 
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Recently Heat Shock Protein 70-2 (HSP 70-2) gene has also been found to be associated with 
pancreatic diseases, and so far various studies have shown conflicting results. So a definite 
role of this genetic polymorphism has not yet been confirmed in this disease 
(7).
 
 
The  Heat shock proteins (HSPs)  act as  chaperones which is meant for cell protection from 
injury causing stimuli. In that way, there abnormal  expression can lead to multiple diseases 
including various maignancies. There were previous studies which showed protective 
function of HSP 70 agnaist cell injuries and acinar cell necrosis of pancreas in animal models 
using  knock-out and transgenic approach, as well as using  standard  methods of heat shock 
protein 70 (HSP70) induction such as thermal stress and  arsenite administration
(8) 
. They are 
named based on their  molecular weight,  like, HSP70 refers to a family of these proteins with 
a molecular weight of  70 kilodaltons  
(22).
 
In 1962, Ritossa noted a typical puffing pattern in the chromosomes of Drosophila when 
induced by a  metabolic inhibitor dinitrophenol
(23)
.  This  finally led to  the identification of 
the stress proteins or heat-shock proteins (HSP). 
 
Functions of Heat Shock Proteins 
1. up regulation in stress 
It was shown that  the concentration of heat shock proteins was increased on exposure to 
different  stressful environmental  conditions. 
2. Role as chaperones   
An important function of heat shock proteins is its role as chaperones, that is it helps in the 
folding and establishment of proper shape of various proteins . This intracellular action helps 
in preventing the unnecessary aggregation of proteins. Through these properties of they helps 
in the protein transportation across the membranes 
(24) . 
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3. Role as House keeping 
Heat Shock Proteins helps in house keeping actions inside the cells by taking all the old 
proteins to the proteosomes and helps in the proper establishment of the new proteins.  
4.  Role in Immunity  
Heat Shock Protein 70 helps in binding of the antigens  and carrying it  to the immune 
system
(25)
.
  
5. Role in Cardiovascular system 
Heat Shock Protein 90 binds both soluble guanylate cyclase and endothelial nitric oxide 
synthase which are involved in vascular relaxation 
(26)
.  
 
The major heat shock protein  for the normal cellular homeostasis in humans is the HSP70. 
The HSPs has got both anti-inflammatory as well as the  proinflammatory effects, in 
regulating the human health. These properties of heat shock proteins  depends on what is the  
cell type, the context  and the site, that is whether it is intracellular or extracellular location. 
The anti-inflammatory effects are ususally intracellular, and is by nuclear factor κB signalling 
inhibition. The cytokine production is ussually as a result of  extracellular effects.  The other 
extracellular effects being the induction of regulatory immune cells and reduced inflammation 
(27)
. HSP70, although usually  is intracellular, but  can be released extracellularly also   when 
the cells are stressed, especially  in the setting of necrosis 
(28)
. 
 
Studies have showed that the induction of heat shock proteins (HSPs) are up regulated in 
acute pancreatitis and also it showed a protective effect in experimental pancreatitis 
(29).
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Certain genotypes of HSP70 are associated with higher output of cytokines in response to any 
inflammatory stimulus. There are three members in HSP 70 gene family which was mapped 
and studied in detail in humans. They include HSP 70-1, HSP 70-2, and HSP 70-HOM, of 
which HSP 70-2 encodes the major heat inducible HSP70.  
 
A genetic polymorphism can be defined as  a genetic variant that appears in at least 1% of 
population. We can exclude  spontaneous mutations that might  have occurred in and spread 
through the descendants of a single family by  setting the cut-off of 1%.  
 
The HSP gene polymorphism results in the defective HSP production with in the cell as well 
as imbalance in the inflammatory cytokines. 
 
Previous studies by Milner et al. identified polymorphism in HSP 70 gene,  polymorphic A to G 
transition PstI site at position 1267 in  HSP 70-2 coding regions
(9)
. Those who are  homozygous for 
this specific  HSP 70-2 G allele was shown to have  reduced  HSP70-2 mRNA expression
 (10)
, and it 
was also shown that this  HSP70-2 –1267 A/G is associated with increased risk for various diseases 
and its poor outcomes 
(32, 33, and 34).
. It was also shown that those having the above mentioned HSP 70-
2 G alleles are at risk for developing acute severe pancreatitis 
(11)
. 
 
It was found in many studies that polymorphism in HSPA1L gene is related to reduced levels 
of inducible HSP70 in monocytes and lymphocytes.  The low levels are correlated much with 
the the CC genotype than the TT genotype 
(36)
. In the same study they could not find any 
specific association between  polymorphism in HSPA1B gene and intracellular HSP70 
response. In another study cardiac failure was found to have association with HSPA1BG 
allele
(37)
. Diabetic ketoacidosis is another health problem that is related to increased 
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extracellular levels of  HSP70 
(38)
,  but its relationship to the HSPA1B or HSPA1L genotype 
is still unknown. Another health issue related to genotypes HSPA1B AG  or HSPA1LCT is 
severe multiple trauma. In those patients with multiple severe trauma and is having the   
above genotypes was found to have a significantly higher plasma concentrations of TNF-α 
and IL-6 than those with GG or TT genotypes 
(39)
.  Also it has been shown in one previous 
study that HSPA1 B AG genotype was significantly associated with a more severe local 
disease in patients with diabetic foot, amputation rate and longer hospital stay than GG 
genotype 
(40)
. 
 
It was demonstrated that there is a strong association between rs1061581,  rs1043618 and 
rs1008438 polymorphisms with high altitude associated pulmonary edema 
(41)
.  Another study 
demonstrated an association between single nucleotide polymorphism (SNP) rs2227956 in 
HSP 70-hom, rs1043618, rs1061581 and noice induced hearing loss 
(42)
. 
 
It was found in previous studies that there is a high risk  that patient can go for a severe 
course of acute pancreatitis, if they have  HSP70-2 G and the TNF-[alpha] – 308 A alleles . 
So assessment of genotype may turn as an important tool for predicting prognosis and 
severity of diseases and for predicting the course of acute pancreatitis. Hence assessment of 
genotype may be used as an important tool to guide treatment and to identify population at 
risk for severe acute pancreatitis. 
 
It is getting more and more clearer that the various genetic polymorphism combinations 
predispose to the occurrence of acute pancreatitis. On the top of that if one or more risk factor 
is added such as metabolic, alcohol or physiological stress etc, it will predispose to acute 
pancreatitis.   
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Some earlier studies have shown the dual role of HSP 70 in various pancreatic diseases. The 
protective role of HSP 70 is that it protects from cellular injury as well as from the necrosis of 
the acinar cells 
(8)
. 
 
There were three studies which assess various polymorphisms in cases with pancreatic 
diseases,  of which two were carried out in cases with acute pancreatitis 
(43, 44)
 and one in 
cases with chronic pancreatitis 
(45)
. While one of the studies evaluated the role of three 
specific polymorphisms (HSP 70-2, TNF-alpha, and CD14 genes) in determining the 
susceptibility to severe acute pancreatitis of different aetiologies, the second study assessed 
the role of CD14, TNF and HSPA1B gene polymorphisms to see for the susceptibility to 
acute alcohol induced pancreatitis. The third one evaluated the role of MCP 1 and HSP 70-2 
genes and its susceptibility to alcoholic induced chronic pancreatitis. 
 
In one recently published Indian study, mutant allele of HSP 70-2 gene (G allele) was 
assessed. This was assessed in cases with acute pancreatitis, chronic pancreatitis and 
pancreatic carcinoma.  In this study, patients with acute pancreatitis with various 
complications like acute fluid collection, ascites, pseudocyst, pleural effusion, any local 
complication, organ failure such as gastrointestinal bleed, respiratory failure, renal failure, 
shock and sepsis were studied for their association with HSP 70 gene polymorphism. 
However, there could not find any significant  association noted in the genotype distribution 
and development of any of such complications. 
 
The possible explanations for the lack of such associations could be due to 1) larger sample 
size that  is required for genetic association studies 2) the different ethnic  composition of 
study population when  compared to other studies, in which the polymorphism distribution 
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was not even comparable among control population  3) the different haplotypes in 
chromosome 6 such as  TNF alpha and beta, the complement components C2, C4 and the  Bf, 
the  enzyme 21 hydroxylase, etc,  which are very much in close proximity with HSP 70-2 
genes  and can also have an impact on the disease severity and for predisposition to the  
development of various complications through the effect of linkage disequilibrium, via 
promoter,  modifier or the suppressor effect. 
 
This study also showed the presence of significantly higher frequency of HSP 70-2 gene 
mutant allele (G allele) in cases with acute pancreatitis and also in pancreatic carcinoma cases 
when compared with the control population. The frequency of mutant allele was higher in all 
the three diseased groups when compared with the control group. There was no association 
noted between this polymorphism and disease severity as well as with the complications. 
However, in cases with chronic pancreatitis though the AG and GG alleles were more 
common, these differences did not reach statistical significance 
(46).
 
 
 TNF, CD 14 and IL-10 gene Polymorphisms 
It was also suggested that there is an association between the risk for pancreatitis with alcohol 
as the etiology and the severity of the disease during its course with the TNF, CD14 and IL-
10 inflammatory gene  polymorphisms. So assessment of genotype may turn as an important 
tool for predicting prognosis and severity of diseases and for predicting the course of acute 
pancreatitis. Hence assessment of genotype may be used as an important tool to guide 
treatment and to identify population at risk for severe acute pancreatitis. 
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Pathogenesis of systemic and local complications in  acute pancreatitis 
In the initial stages there is precursor enzyme activation  which results in damage to the 
pancreatic parenchyma, interstium and vascular endothelium. In various studies, it was 
demonstrated that there is circulatory changes  at the microscopic level, vasoconstriction, 
stasis of the blood at the level of capillaries and finally leading to ischemic injury 
(47)
. These 
further can be damaged through means of ischemia –reperfusion injury. Also it can results in 
edematous pancreatic parenchyma  formation and the so called interstitial pancreatitis. 
(48)
  
 
In some previous studies using animal  models and also in humans, it was shown using 
Indium-111 tagged leukocytes that there is significant infiltration of the pancreatic acinar 
cells with macrophages and neutrophils in animal and human models of pancreatitis 
(49)
. The 
recruitment of the inflammatory cells into these tissues  is largely influenced by  complement 
activation and by subsequent C5a release.  
 
These infiltrated neutrophils and macrophages in turn will result in the release of various 
proteolytic enzymes, lipolytic enzymes, reactive oxygen metabolites.  The  proinflammatory 
cytokines such as interleukins (IL) 1, 6, and 8, the tumor necrosis factor (TNF), and 
arachdonic acid metabolites such as prostaglandins, platelet-activating factor, and 
leukotrienes were also released through these process. In effect, the activation of these 
cytokines is also extended to distant sites apart from the pancreatic and peripancretic tissue, 
as evidenced by detection of significant up-regulation of TNF-a mRNA in the splenic 
mononuclear cells in rat models following induction of acute pancreatitis 
(50)
. These local and 
the systemic inflammatory substances over ride the protecting ability of the antioxidant 
mechanisms within the body. Pancreatic microcirculation is affected through the above 
mechanisms and can results in increased vascular permeability, thrombosis, hemorrhage, and 
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finally pancreatic necrosis. The above mentioned responses in its severe form can lead to 
systemic insult and to the development of SIRS. The various systemic complications,  like 
acute respiratory distress syndrome (ARDS), pleural effusions, hypotension , failure of the 
kidneys and myocardial dysfunction can be as a result of these mechanisms (51).  The  ARDS 
can also explained by the increased  release of activated phospholipase A or called 
lecithinase, that can  digest lecithin, which is considered to be a  a major component of 
surfactant. 
 
Lung injury in cases with severe pancreatitis can also be mediated by up-regulation of 
adhesion molecules. In acute pancreatitis there is increased inflammatory infiltrate in the lung 
tissue, followed by release of cytokines resulting in  up-regulation of P- and E selectin. The 
expression of these selectins correlates with the increased infiltration of CD18 - positive cells 
and neutrophil sequestration in the lung tissue. These are all well  correlated with  histologic 
pulmonary injury and increased activity of  myeloperoxidase  in the lung tissue. Lung injury 
also has been associated with the over expression of VCAM 1 
(52)
 and  increased expression 
of P-selectin through a free radical dependent mechanism which is generated by the damaged 
pancreas. In addition, the trypsin generated complement activation was shown to participate 
in up regulation of the Mac-1 and shedding of the L-selectin on neutrophils in acute 
pancreatitis 
(53).
 
 
Myocardial depression and shock  can well be explained by the hyper catabolic state and 
disturbed peripheral microcirculation with resulting reduced tone of the vessels and thereby 
leads to  reduced tissue oxygenation
(54)
. 
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Acute kidney injury  in cases with  acute pancreatitis has been attributed to hypovolemia and 
hypotension. Various metabolic complications such as diabetic ketoacidosis, hyperglycemia, 
hyperlipidemia, hypoglycemia and hypocalcemia have also been described. The pathogenesis 
of hypocalcemia is multifactorial and it includes calcium soap formation, binding of calcium 
by the free fatty acid–albumin complexes, hormonal imbalances such as parathormone, 
calcitonin, glucagon), and the intracellular translocation of calcium. 
 
During the natural course of acute pancreatitis the permeability of the gut is compromised, 
leading to the translocation of bacteria, which can result in septicaemia . The breach in gut 
barrier is thought to be secondary to the pancreatitis-induced gut arteriovenous shunting and 
also as a consequence of ischemia caused by hypovolemia 
(55)
.  Isolation of common enteric 
organisms from the pancreatic infection supports the notion that these organisms have 
translocated from the gastrointestinal tract. 
 
In about 30% of cases with severe acute pancreatitis bacterial sepsis occurs in the pancreatic 
and the peripancreatic tissues .  Infection carries the potential of a multiorgan failure and its 
consequences, which could be fatal event. Bacterial translocation and the endotoxemia, were 
proposed as mechanisms behind the violent cytokine response observed in acute pancreatitis. 
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Fig 1: Various events in acute pancreatitis . With the initiation of  pathophysiological changes 
inside acinar cell (left  side sequence), signal metabolites induces  an extra pancreatic 
inflammatory response (right side sequence). These processes interact with each other  and 
contribute to the progression of the disease. 
 
CLINICAL FEATURES  
Acute pancreatitis patients, usually present with pain abdomen and vomiting. In about 90% of 
cases nausea and vomiting can be present.  
 
Pain typically starts in epigastrium and may be radiating to the back . Abdominal examination 
may reveal tenderness in the epigastrium. In mild cases, usually there will be an uneventful 
recovery and may require only few days of admission in hospital. In severe cases, pain may 
be severe with increase in heart rate, tachypnoea, decreased urine output and 
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hypotension.There can be various signs on abdominal examination like Cullens and Gray 
Turners signs. In severe cases death also can occur 
(7)
.  Such patients can be grouped as severe 
acute pancreatitis when they present with /develop organ failure and or with local 
complications such as fluid collections,  necrosis, abscess, or pseudocyst 
(1)
. 
 
Respiratory signs such as pleural effusions especially on the left with or without left sided 
basal lung collapse, wheezing, and sometimes with basal crepitations.  Cullen‟ s sign is a  
faint blue discolouration noted  around the umbilicus ( due to haemoperitoneum)  and Grey -
Turner‟s sign is a  a blue red purple or brown discolouration of the flanks  (due to 
retroperitoneal haemorrhage) may  observed after 48 hr. Sometimes, erythematous skin 
nodules due to subcutaneous fat necrosis can also be found. 
 
The differentials for  acute pancreatitis include perforation peritonitis, intestinal ischemia , 
intestinal obstruction, renal or biliary colic, acute myocardial infarction  etc.  . 
 
SEVERITY OF ACUTE PANCREATITIS    
Acute pancreatitis can be either  mild ( 85% cases) or can be severe (15% cases). Those acute 
pancreatitis which is associated with organ failure and or associated with local complications 
such as necrosis, abscess or pseudocyst and is often characterised by an extensive 
peripancreatic and intrapancreatic fat necrosis, haemorrhage and parenchymal necrosisis is 
grouped under severe.. 
 
Severe Acute Pancreatitis: 
Acute pancreatitis which is  associated with organ failure  and /or local complications, such as 
necrosis, abscess, or pseudocyst is grouped as severe acute pancreatitis 
(1)
. 
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Acute mild  Pancreatitis: 
Those acute pancreatitis which is  associated with minimal or transient organ dysfunction, 
leading to an uneventful recovery, and which lacks the described features of severe acute 
pancreatitis is grouped as acute mild pancreatitis 
(1)
. 
Acute Fluid Collections: 
It is the collection of the fluid which occurs early  in the course of acute pancreatitis, and is  
located in or around  the pancreas, which lacks  a wall of granulation or fibrous tissue 
(1)
. 
Pancreatic Necrosis 
These are diffusely or focally affected  well marginated zones of non enhancing  pancreatic 
parenchyma which is nonviable, larger than 3 cm or involve more than 30% of the area of the 
pancreas,  which is typically associated with peripancreatic fat necrosis 
(1)
. 
Acute Pseudocyst: 
A pseudocyst is a collection of pancreatic secretions which arises as a result of acute 
pancreatitis, pancreatic trauma, or chronic pancreatitis and is enclosed by a wall of fibrous or 
granulation tissue 
(1)
. 
Pancreatic Abscess: 
It is a well defined circumscribed  collection of pus, with little or no pancreatic necrosis.  
Usually it occurs in close proximity to the pancreas, and arises as a result of acute pancreatitis 
or pancreatic trauma 
(1)
. 
Organ failure: 
Organ failure comprise hypotension with systolic blood pressure <  90 mm Hg, pulmonary 
insufficiency ith a pulmonary arterial oxygen saturation of  60 mm Hg or less, kidney injury 
with a creatinine >  2 mg/dl after proper  rehydration, or gastrointestinal bleeding (more than 
500 ml/24 hours) 
(1)
. 
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The imporant other systemic complications are disseminated intravascular coagulation 
(platelet count of less than 1 lakh , fibrinogen of less than 1.0 g/L,  and fibrin degradation 
split products  of  more than 80 pg/mL) or severe metabolic disturbances  such as 
hypocalcemia (calcium level less than or equal to 7.5 mg/dL) 
(1)
. 
 
Most of severe acute pancreatitis mortality is associated with the organ failure. In the early 
stages, organ failure is resulting from the inflammatory mediators released by systemic 
inflammatory response syndrome even if there is no infection. In the septic phase, organ 
failure occurs because of the sepsis. So organ failure is common in the genesis of severe acute 
pancreatitis.   Previous studies showed that in severe acute pancreatitis, organ failure occurred 
in about 72-90.3 %, with one organ failure in 24.7-37 % of  cases, multiple organ failure in 
about  35- 65.6 %. Respiratory failure is the most common single organ failure reported 
(39.1-63 %), followed by the cardiovascular failure (23-37.7 %), then liver  failure (20.7 %), 
and followed by acute kindney injury (8.5-13 %) 
(56)
. Previous studies also showed the 
mortality rate was 45 % in patients with multiple organ failure, and was 11 % in single organ 
failure group 
(57).
 
 
If there is a failure to improve in the condition of patient  within 48 - 72 hr of supportive 
treatment, dynamic contrast enhanced CT of the abdomen should be taken to determine the 
severity of the disease. 
 
Several prognostic scoring systems have been suggested  to assess the severity of pancreatitis. 
The Ranson scoring system uses series of 11 prognostic signs, where severe acute pancreatitis 
is labelled if  three or more criteria is present. A score of 10 or more during the first 48 hours 
of onset of symptoms while using the  APACHE II criteria, indicates severe acute 
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pancreatitis.
 
Balthazar score predicts severity of acute pancreatitis based on the abdominal CT 
appearances of pancreas which includes the presence or absence of pancreatic necrosis.
 
The 
biochemical markers such as C-reactive protein, pancreatitis-associated peptide,  neutrophil 
elastase, interleukins 1, 6, 8, 10 and soluble TNF receptors and  urinary trypsinogen 
activation peptide can be used to assess severity of acute pancreatitis 
(58)
. In 
  
another study 
they concluded that a the peak level of plasma C-reactive protein peak of more than 210 mg/L 
on day 2 - 4 or more than 120 mg/L at day 7 was as predictive as in any other multiple 
scoring systems 
(59).
 
 
Another scoring system used was Simplified Glasgow Score which we have used in our 
study. In this score of more than 2 is categorised as severe. 
 
Variable include: 
Age> 55 years 
PaO2 < 60 mm Hg 
WBC > 15,000 / mm3 
Ca 2+ (uncorrected <8 mg % 
Urea >45 mg % 
Albumin <3.2 g % 
 
For cases with acute pancreatitis, there is no  specific treatment. These cases requires  
aggressive supportive management. This helps in reducing pancreatic secretion through  
reducing enteric stimulation. Other supportive treatments include administering of fluid, 
correction of electolytes  and  to  provide relief from pain.   
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We proposed that polymorphisms in the Heat Shock Protein 70 gene may play a significant 
role in determining whether the illness manifests as a mild acute pancreatitis or as a severe 
acute pancreatitis, i.e. it may have a disease-modifying effect.  So assessment of genotype 
may turn as an important tool for predicting prognosis,  severity of diseases and for predicting 
the course of acute pancreatitis. Therefore, genotype assessments may also be used to guide 
treatment or to identify populations at risk for developing severe acute pancreatitis. 
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METHODS 
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Study design  
This was a cross sectional study performed in the Christian Medical College, Vellore. 
 
Inclusion criteria  
Cases of acute pancreatitis the diagnosis of which was made on basis of history and 
investigations, including radiological evidence of acute pancreatitis and laboratory evidence 
of serum amylase greater than 3 times upper limit of normal 
 
Exclusion criteria 
Cases with evidence of chronic pancreatitis/tumours (ductal dilatation, ductal or  
Parenchymal calcification or pancreatic mass).  
Patient or relative not willing to give written informed consent. 
 
Study setting and Population: 
The study was conducted in the department of Gastrointestinal Sciences in CMC Hospital, 
Vellore from February 2011 - Dec 2012. Data were collected from the patients with the 
diagnosis of acute pancreatitis of various aetiologies. They were recruited from the 
gastroenterology ward and also from the emergency services. They all had met the diagnostic 
criteria for acute pancreatitis, and also the inclusion and exclusion criteria. Purpose of the 
study was explained to these patients and an informed consent was taken. Adequate venous 
blood samples were then taken for further investigations. In the case of  a few patients who 
were first admitted in another hospital and then transferred here the laboratory parameters in 
the first few days that were  needed to calculate some scores (eg.SGS) of initial days of the 
disease of these patients were obtained from their outside hospital reports .  In cases with 
diagnostic confusions or in cases with suspected complications, further investigations like 
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computed tomography was taken. No additional clinical laboratory tests were performed for 
the study other than those dictated for clinical care. 
 
Informed Consent Process  
Those patients who met the criteria were informed about the background and purpose of the 
study and they were invited to participate. If they were willing to participate, then written 
consent was obtained from the patient as per consent form appended. 
 
Ethics Committee review  
The Human Ethics Committee of CMC Vellore reviewed and approved the proposal and 
consent forms. 
 
Study Monitoring  
The study was an investigator-initiated study conducted in Christian Medical College, 
Vellore. The candidate conducting this study personally ensured the entry criteria of the 
patient and collected the relevant clinical and laboratory data from the patient. Consecutive 
patients were enrolled, subject to consenting. The molecular biology testing was performed in 
a research laboratory attached to the department by a specialist in this area .The clinical 
investigator was blinded to the genotype analysis, while the molecular biologist was blinded 
to the clinical data. 
 
Methods of the Study 
This study was conducted at Christian Medical College Vellore, Tamilnadu. Relevant clinical 
and laboratory data were collected from the patients by the medical officer in charge of the 
37 
 
study, once they received the informed consent after ensuring entry criteria. No additional 
tests were performed for disease categorisation other than those dictated for clinical care. 
 
Sample size  
From previous studies we determined that the inflammatory HSPA1B AG genotype was  
present in approximately half of our population 
(40)
. The hypothesis was that this single 
nucleotide polymorphism (or other SNPs in the same gene) may have a „modifier‟ effect on 
the course of acute pancreatitis. Therefore we expected that 50% of patients with acute 
pancreatitis would also have this inflammatory genotype. We have assumed that one third of 
patients with acute pancreatitis would have acute severe pancreatitis and two thirds would 
have acute mild pancreatitis. Assuming a relative risk of 3 for the development of severe 
pancreatitis in someone with an inflammatory genotype compared to a non-inflammatory 
genotype, we calculated the sample size of 124 patients to disprove the null hypothesis with a 
study power of 80% and type I error of 0.05.  
 
The patients were those who were admitted to Gastroenterology ward or to the emergency 
ward with a diagnosis of acute pancreatitis were included. The following definitions were 
used in the study. 
 
Severe Acute Pancreatitis: 
Acute pancreatitis which is  associated with organ failure  and /or local complications, such as 
necrosis, abscess, or pseudocyst is grouped as severe acute pancreatitis  
(1)
. 
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Acute mild  Pancreatitis: 
Those acute pancreatitis which is  associated with minimal or transient organ dysfunction, 
leading to an uneventful recovery, and which lacks the described features of severe acute 
pancreatitis is grouped as acute mild pancreatitis  
(1)
. 
Acute Fluid Collections: 
It is the collection of the fluid which occurs early  in the course of acute pancreatitis, and is  
located in or around  the pancreas, which lacks  a wall of granulation or fibrous tissue 
(1)
. 
Pancreatic Necrosis 
These are diffusely or focally affected  well marginated zones of non enhancing  pancreatic 
parenchyma which is nonviable, larger than 3 cm or involve more than 30% of the area of the 
pancreas,  which is typically associated with peripancreatic fat necrosis 
(1)
. 
Acute Pseudocyst: 
A pseudocyst is a collection of pancreatic secretions which arises as a result of acute 
pancreatitis, pancreatic trauma, or chronic pancreatitis and is enclosed by a wall of fibrous or 
granulation tissue 
(1)
. 
Pancreatic Abscess: 
It is a well defined circumscribed  collection of pus, with little or no pancreatic necrosis.  
Usually it occurs in close proximity to the pancreas, and arises as a result of acute pancreatitis 
or pancreatic trauma 
(1)
. 
Organ failure: 
Organ failure comprise hypotension with systolic blood pressure <  90 mm Hg, pulmonary 
insufficiency ith a pulmonary arterial oxygen saturation of  60 mm Hg or less, kidney injury 
with a creatinine >  2 mg/dl after proper  rehydration, or gastrointestinal bleeding (more than 
500 ml/24 hours) 
(1)
. 
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The imporant other systemic complications are disseminated intravascular coagulation 
(plateletcount of less than 1 lakh , fibrinogen of less than 1.0 g/L; and fibrin degradation split 
products  of  more than 80 pg/mL) or severe metabolic disturbances  sucha as hypocalcemia 
(calcium level less than or equal to 7.5 mg/dL) 
(1)
. 
 
Relevant clinical and laboratory data were collected from the patients by a medical officer in 
charge of the study once they received the informed consent after ensuring entry criteria. 
9 ml of venous blood samples were collected in EDTA coated vacutainer tubes after 
obtaining informed written consent. Genomic DNA was isolated using standard salting out 
procedure. Genomic DNA from mononuclear cells in blood was extracted  by phenol–
chloroform extraction and kept −20°C for storage. Appropriate primers and restriction 
enzymes were used to genotype the HSPA1B A1538G, HSPA1L C2437T, rs1008438 and 
rs1043618 loci. 
 
The HSP70 polymorphisms rs1061581 and rs2227956 were detected by PCR-RFLP method 
and  rs1008438 and rs1043618 were detected by allele-specific PCR. The PCR reactions were 
of 20 μl volume and each reaction mix contained 1x taq DNA polymerase master mix Red 
(Ampliqon), 250nM of forward and reverse primers (Sigma genosys).  
The thermal cycling protocol for rs1061581, rs2227956, rs1008438, and rs1043618 
comprised of initial denaturation at 95 C for 5 min, cycle denaturation at 94 C for 30 sec, 
annealing temperature at 58 C and 62 C for 30 sec, extension at 72 C for 30 sec, and the 
cycle was repeated for 34 more times, final extension at 72 C for 5 min. The PCR products 
were checked for amplification by resolving on 2% agarose gel electrophoresis and checked 
with UV transilluminator (Vilbert Lourmat).  
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Then the amplified samples were digested with 2 units of restriction enzymes, PstI and NcoI 
(MBI Fermentas) respectively for rs1061581 and rs2227956 analysis at 37 C for 16 hours. 
The digested PCR products were resolved on 2% agarose gel electrophoresis and the gel 
patterns were documented using a gel documentation system (Vilbert Lourmat, France).  
 
The genotypes were assigned for the PCR-RFLP analysis as given in the table. 
SNP Forward primer Reverse primer 
Product 
size 
Restriction 
enzyme 
Restriction 
fragments 
rs1061581 CATCGACTTCTACACGTCCA CAAAGTCCTTGAGTCCCAAC 1117 Pst1 
AA -1117 
GG – 936, 
181 
rs2227956 GATCCAGGTGTATGAGGG 
GTAACTTAGATTCAGGTCTG
G 
705 Nco1 
 CC – 705 
TT – 550, 
155 
rs1008438 
CAGGACGGGAGGCGAAAC 
CAGGACGGGAGGCGAAAA 
CACAGGTTCGCTCTGGGAA 219 - - 
rs1043618 GCTCGGTGATTGGCTCAGAA 
CTGCTCTCTGTCGGCTCG 
CTGCTCTCTGTCGGCTCC 
282 - - 
 
 
Statistical methods: 
The data of the present study were recorded manually and into the computer and after its 
proper validation, checked for error, coding & decoding were compiled and analyzed using 
the software SPSS 11.5 for windows. Categorical data was compared using the Pearson Chi 
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square test, while continuous data was compared using two-tailed independent t tests. All the 
continuous variables were expressed as mean ± standard deviation. 
 
Patients who were discharged against medical advice were discharged in moribund condition. 
For purpose of statistical analysis they were clubbed with those who died. In acute 
pancreatitis we considered that HSP gene 70 polymorphism will play as a modifier role rather 
than a causative role in the natural history of acute pancreatitis. 
 
Apart from seeing the relationship between polymorphism with severity of pancreatitis, we 
also looked   into the possible association between HSP 70 gene polymorphism and 
occurrence of organ failure, length of hospital stay including the duration of Intensive Care 
Unit stay and mortality associated with this disease.   
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RESULTS 
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Blood samples and relevant clinical data were collected from 127 patients admitted in the 
Gastroenterology ward with acute pancreatitis. Genetic analysis for the HSP 70 single 
nucleotide polymorphisms under study was performed only in 121 patients as there was a 
failure in DNA amplification process in 6 samples. Of the 127 patients, 61 were mild and 66 
were severe. The baseline demographic data of the patients enrolled in this study were 
tabulated and given below 
Table 1. General characteristics of the patients who were enrolled in the study. Some values 
shown are actual numbers while the others are mean + SD. 
Particulars Total Mild Severe 
Total cases 127 61 66 
Age(years) 40.17 ± 13.12 39.82 ± 12.30 40.50 ± 13.94 
Male : Female 2.7 :1 2.1:1 3.64:1 
SGS score 1.96 ± 1.90 0.62 ± 0.68 3.23 ± 1.80 
CRP(mg/L) 181.99 ± 63.374 212.51 ± 90.74 152.88 ± 59.76 
Amylase (U/L) 1004.92 ± 1055.39 1061.50 ± 1092.61 962.45 ± 1028.06 
Lipase(U/L) 1938.62 ± 2516.68 2062.98 ± 2489.17 1820 ± 2556.28 
PCV (%) 47.37 ± 39.88 45.86 ± 41.11 48.79 ± 38.92 
Hospital stay 
(days) 11.81 ± 16.48 4.98 ± 2.73 18.32 ± 20.95 
ICU stay (days) 3.24 ± 8.04 0.08 ± 0.45 6.26 ± 10.39 
 
The mean age of patients participated in the study was 40.17 ± 13.12 years. The mean age of 
patients in mild and severe group was 39.82 ± 12.30 and 40.50 ± 13.94 respectively. The 
male female ratio was 2.7:1, 2.1:1, and 3.64:1 respectively for the total patients group, mild 
and severe group. The mean simplified glasgow score was 1.96 ± 1.90, 0.62 ± 0.68 and 3.23 ± 
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1.80 for total, mild and severe pancreatitis group. The mean CRP was181.99 ± 63.374, 212.51 
± 90.774 and 152.88 ± 59.76 for the the above respective groups. The mean amylase for the 
above group was 1004.92 ± 1055.39, 1061.50 ± 1092.61 and 962.45 ± 1028.06. The mean 
lipase was 1938.62 ± 2516.68, 45.86 ± 41.11 and 1820 ± 2556.28 for total group, mild and 
severe group respectively. Mean PCV were 47.37 ± 39.88, 45.86 ± 41.11 and 48.79 ± 38.92 
for the above three groups. The mean total hospital stay for total group, mild and severe 
group was 11.81 ± 16.48, 4.98 ± 2.73 and 18.32 ± 20.95 respectively. The mean number of 
ICU stay was 3.24 ± 8.04, 0.08 ± 0.45 and 6.26 ± 10.39 days respectively. 
Fig :1 showing Age and Sex distribution 
 
 
 
Of the total 127, 93 /127 (74%) were male and 34/127 (26%) were females. 
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Fig :2 Disease severity and chest x-ray findings 
Simplified Glasgow Scoring                                   Chest X - ray findings  
 
 
 
 
 
 
 
 
 
 
73 /127 (57%) patients had an SGS < 2 and 54 /127 (43%) had SGS > 2.  60.62% had normal 
chest xray, 22.07% had bilateral effusion, and 17.32 % had left sided alone. 2/127 (0.78%) 
had ARDS features on Xray at time of admission 
Fig 3: Showing the Local complications 
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52/127 (41.73%) had local complications. Acute fluid collection in 37 %( 47/127), 
pseudocyst in 7.08 %(9/127), pancreatic necrosis more than 30 % in 7/127(5.51%) and  
0.7%(1/127) had abscess collection. 
Fig 4: showing organ failure and its distribution pattern 
 
 
 
 
 
  
 
 
30/127 had organ failure (24.04%) of which 25 had respiratory complications, 14 had 
cardiovascular, 08 had renal, and 01 had GI bleed related complications. 50% (15 / 30) of 
patients who had organ failure had multiple organ failure.  
                                                                                     
Fig 5: The pattern of infection in culture positive acute pancreatitis patients  
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17/127 had blood culture grown for infectious agents, of whom 08 had Klebsiella, 07 had 
Ecoli, and 01 each had Acinetobacter, Enterococci and Candida .Ascitic culture grew 
Klebsiella in three and Ecoli in one. Urine had grown Ecoli, Klebsiella and Enterococci in 1 
patient each.  Sputum   grew Klebsiella in two patients. 
 
Fig 6: showing the need for ventilatory support 
 
 
17/127 (13.3%) required ventilatory support, of which 15required invasive ventilatory 
support. 
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Fig 7: showing the need for Pressure support and Dialysis support                                                             
                                                                    Dialysis support 
 
 
 
 
 
 
 
 
 
 
17/127 (13.38%) required pressure support during their hospital stay and about 4% (5/127) 
required dialysis support. 
Fig 8: showing the pattern of mode of nutrition 
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Of all the 127 patients 49 patients (38.58%) required Nasojejunal feeds for their nutrition, 
3/127(2.36%) required Total Parenteral Nutrition, and the rest 75/127 (59.05%) was managed 
by oral feeding.   
Fig 9: showing the outcomes in acute pancreatitis (surgery/ alive / dead) 
 
  
 
 
 
 
 
 
6/127(4.72%) required surgery. Of the 127 patients 114 (89.76%) were alive at the time of 
discharge , 5.51% (7/127) were discharged agnaist medical advice, and 6/127 (4.72%) died 
during the hospital stay. 
Fig 10:showing aetiological distribution and severity 
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Alcohol was the most common aetiological factor (48.8% -62/127), second being biliary 24% 
(30 /127) followed by idiopathic (20%), Post ERCP (6.29%) and finally drugs (1/127) for 
which Neomercazole was found to be the culprit.  
Of all the 127 patients 52% (66/127) had severe disease course where as 48% (61/127) had a 
mild course. 
Table 2: Distribution of first /recurrent episodes of acute  pancreatitis 
First / 
recurrent 
  
Mild Severe 
 
Total 
First   51 61 112 
Recurrent   11 4 15 
Total   62 65 127 
 
Out of the total 127 patients 15/127(11.8%) had recurrent episodes of pancreatitis of which11 
were mild and 4 were severe pancreatitis. 
 
Table 3: Aetiology of recurrent acute pancreatitis 
Aetiology Total group Mild group Severe group 
Idiopathic 7 6 1 
Biliary 4 3 1 
Alcohol 3 2 1 
Post ERCP 1 0 1 
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Of all the causes of recurrent acute pancreatitis idiopathic group stands first, 7/15 in the total 
group and 6/11in the mild group. This was followed by biliary, alcohol and post ERCP 
causes. In the severe group the aetiology behind recurrent acute pancreatitis were shared one 
each between idiopathic, biliary, alcoholic and post ERCP.  
Fig: 11 showing rs 1043618 gene polymorphism 
Rs1043618 (allele-specific PCR)
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Fig: 12 showing rs 1008438 gene polymorphism 
Rs1008438 (allele-specific PCR)
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C
219
219
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Fig: 13 showing rs 1061581 gene polymorphism 
Rs1061581 (PCR-RFLP)
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Fig :14 showing rs2227956gene polymorphism 
 
Figures 11 -14 is showing polymorphisms in various SNP namely rs 1043618,   
rs 1008438 , rs 1061581 and rs2227956 
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Table: 4 showing various distribution pattern of rs2227956 gene polymorphism 
 Yes /no CC CT TT P Value 
Organ failure 
Yes 0 4 25 
0.235 
No 1 26 65 
ICU stay 
Yes 0 7 33 
0.316 
No 1 23 57 
Pulmonary  
insufficiency 
Yes 0 3 23 
0.173 
No 1 27 67 
Surgery 
Yes 0 0 6 
0.337 
No 1 30 84 
Alive 
Yes 1 29 78 
0.291 
No 0 1 12 
Pressure support 
Yes 0 1 16 
0.132 
No 1 29 74 
severe 
Yes 0 12 52 
0.136 
No 1 18 38 
 
Table 4 showing rs 2227956 gene   polymorphism   distribution pattern for the variables in 
acute pancreatitis. Unpooled data analysis did not reveal any statistical significance. Since the 
numbers of patients in the homozygous CC groups were too small to make any conclusion, 
we further done a pooled gene analysis (CC/CT vs.  TT)  for the above variables.  
Table  : 5  showing various distribution pattern of rs1008438  gene polymorphism 
 Yes /no AA AC CC P Value 
Organ failure 
Yes 1 20 8 
0.425 
No 1 73 18 
ICU stay 
Yes 1 28 11 
0.443 
No 1 65 15 
Pulmonary 
insufficiency 
Yes 0 18 8 
0.345 
No 2 75 18 
Surgery 
Yes 0 5 1 
0.902 
No 2 88 25 
Alive 
Yes 2 82 24 
0.738 
No 0 11 2 
Pressure support 
Yes 1 13 3 
0.320 
No 1 80 23 
severe 
Yes 2 47 15 
0.328 
No 0 46 11 
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Table 5 showing rs1008438 gene   polymorphism   distribution pattern for the variables in 
acute pancreatitis. Unpooled data analysis did not reveal any statistical significance. Since the 
numbers of patients in the homozygous AA groups were too small to make any conclusion, 
we further done a pooled genetic analysis (AA/AC vs.  CC)  for the above variables.  
 
Table: 6  showing various distribution pattern of rs1043618  gene polymorphism 
 Yes /no CC CG GG P Value 
Organ failure 
Yes 8 17 4 
0.707 
No 33 47 12 
ICU stay 
Yes 14 18 8 
0.246 
No 27 46 8 
Pulmonary 
insufficiency 
Yes 6 16 4 
0.422 
No 35 48 12 
Surgery 
Yes 2 4 0 
0.588 
No 39 60 16 
Alive 
Yes 35 58 15 
0.574 
No 6 6 1 
Pressure support 
Yes 6 9 2 
0.979 
No 35 55 14 
severe 
Yes 23 31 10 
0.530 
No 18 33 6 
 
Table 6 showing rs1043618 gene   polymorphism   distribution pattern for the variables in 
acute pancreatitis. Unpooled data analysis did not reveal any statistical significance with any 
of the above variables. 
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Table : 7  showing various distribution pattern of rs1061581  gene polymorphism 
 Yes /no AA AG GG P Value 
Organ failure 
Yes 5 16 8 
0.575 
No 22 52 18 
ICU stay 
Yes 8 21 11 
0.524 
No 19 47 15 
Pulmonary 
insufficiency 
Yes 4 14 8 
0.355 
No 23 54 18 
Surgery 
Yes 0 5 1 
0.316 
No 27 63 25 
Alive 
Yes 23 61 24 
0.693 
No 4 7 2 
Pressure support 
Yes 3 11 3 
0.770 
No 24 57 23 
severe 
Yes 15 34 15 
0.760 
No 12 34 11 
 
Table 7 showing rs1061581 gene   polymorphism   distribution pattern for the variables in 
acute pancreatitis. Unpooled data analysis did not reveal any statistical significance with any 
of the above variables. 
Table: 8 showing various distribution pattern of rs2227956 gene polymorphism 
(Pooled data CC/CT genotypes vs TT genotypes) 
 Yes /no CC/CT TT P Value 
Organ failure 
Yes 4 25 
0.094 
No 27 65 
ICU stay 
Yes 7 33 
0.150 
No 24 57 
Pulmonary 
insufficiency 
Yes 3 23 
0.063 
No 28 67 
Surgery 
Yes 0 6 
0.140 
No 31 84 
Alive 
Yes 30 78 
0.117 
No 1 12 
Pressure support 
Yes 1 16 
0.044 
No 30 74 
severe 
Yes 12 52 
0.067 
No 19 38 
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Table: 8 showing pooled data distribution pattern of rs2227956 gene polymorphism in 
patients with the above mentioned variables. Since the numbers of patients who were 
homozygous CC genotype was too small to make any conclusion, the CC/CT groups were 
pooled and were compared against homozygous TT group for the further statistical analysis. 
This pooled data analysis showed significant association between homozygous TT genotype 
and need for pressure support (P = 0.044). Some of the other variables like overall organ 
failure, pulmonary insufficiency, and over all severe pancreatitis showed a trend towards 
association with the correlation with TT genotype.  
Table: 9 showing various distribution pattern of rs1008438 gene polymorphism 
(Pooled data AA/AC genotypes vs CC genotypes) 
 Yes /no AA/AC CC P Value 
Organ failure 
Yes 21 8 
0.359 
No 74 18 
ICU stay 
Yes 29 11 
0.258 
No 66 15 
Pulmonary 
insufficiency 
Yes 18 8 
0.193 
No 77 18 
Surgery 
Yes 5 1 
0.768 
No 90 25 
Alive 
Yes 84 24 
0.571 
No 11 2 
Pressure support 
Yes 14 3 
0.678 
No 81 23 
severe 
Yes 49 15 
0.580 
No 46 11 
 
Table: 9 showing pooled data distribution pattern of rs1008438 gene polymorphism in 
patients with the above mentioned variables. Since the numbers of patients in the 
homozygous AA groups were too small to make any conclusion, the AA/AC groups were 
pooled together and were compared against homozygous CC group for the further statistical 
analysis. This pooled data genetic analysis also did not revealed any statistical correlation.  
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Table 10: showing correlation between number days in hospital and number of days 
stayed in ICU against rs1008438 gene polymorphism (pooled data) 
 
Variable  AA/AC 
Mean +/- SD 
CC 
Mean +/- SD 
P Value 
Hospital stay in 
days  
11.16±13.993 10.69±16.65 0.886 
ICU stay in days 3.42±8.829 2.69±4.831 0.687 
 
The mean number of days stayed in hospital in AA/AC pooled groups and CC genotype 
groups were 11.16±13.993 and 10.69±16.65 respectively and the corresponding numbers for 
days stayed in ICU were 3.42±8.829 and 2.69±4.831days respectively. The P value of both 
these variables did not show any statistical correlation with the rs1008438 gene 
polymorphisms. 
Table 11 : showing correlation between number days in hospital  and number of days 
stayed in ICU  against rs1043618 gene polymorphism (pooled data) 
 
Variable  GG/CG 
Mean +/- SD 
CC 
Mean +/- SD 
P Value 
Hospital stay in 
days  
11.21±16.425 10.76±10.034 0.871 
ICU stay in days 3.44±9.284 2.93±5.255 0.745 
 
The mean number of days stayed in hospital in GG/CG pooled groups and CC genotype 
groups were 11.21±16.425 and 10.76±10.034 respectively and the corresponding numbers of 
days stayed in ICU were 3.44±9.284 and 2.93±5.255 days respectively. The P value of both 
these variables did not show any statistical correlation with the rs1043618 gene 
polymorphisms. 
Table 12 :  showing correlation between number days in hospital  and number of days 
stayed in ICU  against rs2227956 gene polymorphism (pooled data) 
 
Variable  CC/CT 
Mean +/- SD 
TT 
Mean +/- SD 
P Value 
Hospital stay in 
days  
8.16±8.564 12.06±16.00 0.199 
ICU stay in days 1.42±3.374 3.90±9.142 0.031 
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The mean number of days stayed in hospital in CC/CT pooled groups and TT genotype 
groups were 8.16±8.564 and 12.06±16.00 respectively and the corresponding numbers of 
days stayed in ICU were 1.42±3.374 and 3.90±9.142 days respectively. The number of days 
stayed in ICU were found to have a statistically significant association with homozygous TT 
genotype (P = 0.031). The number of days stayed in hospital did not show any significant 
correlation with any of the above genotypes. 
                                  
 
Fig 15 showing number of days spent in ICU in each group (CC/CT and TT genotype group)    
 
The bars represent Mean and Standard Error of Mean. The P value was calculated using 
 
unpaired t-test with Welch‟s correction (for non-equal variances). 
 
Table 13: showing correlation between number days in hospital and number of days 
stayed in ICU against rs1061581 gene polymorphism (pooled data) 
 
Variable  AA/AG 
Mean ± SD 
GG 
Mean +/- SD 
P Value 
Hospital stay in 
days  
11.16±13.993 10.69±16.656 0.886 
ICU stay in days 3.42±8.829 2.69±4.831 0.687 
 
The mean number of days stayed in hospital in AA/AG pooled groups and GG genotype 
groups in patients with rs1061581 were 11.16±13.993 and 10.69±16.656 respectively and the 
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corresponding numbers of days stayed in ICU were 3.42±8.829 and 2.69±4.831 days 
respectively. The P value of both these variables did not show any statistical correlation with 
the rs1061581 gene polymorphisms. 
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DISCUSSION 
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Acute pancreatitis is defined as a process involving inflammation of pancreas, the 
surrounding tissues as well as distant organs 
(1).
 The initial insult of premature activation of 
enzyme precursors is due to an abrupt increase in the calcium levels in the cytosol
(17)
.  This in 
turn leads to pancreatic parenchymal destruction with activation of coagulation, kinin, 
complement and fibrinolytic  cascades with increased release of cytokines and reactive 
oxygen metabolites. These results in massive release in the inflammatory cytokines like  
TNF-α, IL-1, IL-6, IL-8, platelet-activating factor along with  reactive oxygen metabolites. 
The massive inflammatory response resulting from the above changes results in the systemic 
manifestations of acute pancreatitis. This in turn can leads to increased capillary permeability, 
hypotension, respiratory and renal failures requiring dialysis and ventillatory supports.   
  
The major heat shock protein  for the normal cellular homeostasis in humans is the HSP70. 
The HSPs has got both the  anti-inflammatory as well as the  proinflammatory effects, in 
regulating the human health. These properties of heat shock proteins  depends on what is the  
cell type, the context  and the site ,that is whether it is intracellular or extracellular location. 
The anti-inflammatory effects are ususally intracellular, and is with nuclear factor κB 
signalling inhibition. The cytokine production is ussually as a result of  extracellular effects 
The other extracellular effects being the induction of regulatory immune cells and reduced 
inflammation 
(27)
. HSP70, although usually  is intracellular.  But this can be released 
extracellularly also   when the cells are stressed, especially  in the setting of necrosis 
(28 
 
 
Studies have showed that the induction of heat shock proteins (HSPs) are up regulated in 
acute pancreatitis and also it showed a protective effect in experimental pancreatitis 
(29).
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Certain genotypes of HSP70 are associated with higher output of cytokines in response to any 
inflammatory stimulus. 
 
So Genotype assessments may be important prognostic tools to predict disease severity and the course 
of acute pancreatitis. Therefore, genotype assessments may also be used to guide treatment or to 
identify risk populations for severe acute pancreatitis. This study was done to determine whether 
there is any association between Heat Shock Protein 70 gene polymorphisms and severity of illness 
and hospital outcomes in patients with acute pancreatitis. 
 
The mean age of patients in our study was around 40 years and there was a male 
predominance. These can be explained by the fact that, the most common reason found in our 
study was alcohol (48.8% - 62/127) and in India consumption of alcohol is more common in 
males than females. This was similar to the findings that were observed in a study conducted 
in North India by Pooja et al (46).In this study, alcohol was the most common etiological 
factor (50%) and there was a male predominance. 
 
The mean Simplified Glasgow score was 1.96 ± 1.90 in the total study group, with a value of 
0.62 ± 0.68 in the mild group and 3.23 ± 1.80 in the severe group. The raised SGS in the 
severe group can be explained by the severity of the illness. 
 
Mean PCV observed in the study population (47.37 ± 39.88) was higher than normal, which 
could be due to inflammatory response and extravasations of fluid into the third space, 
leading to haemoconcentration. Slightly greater PCV noted in the severe group when 
compared with the mild group (48.79 ± 38.92 vs. 45.86 ± 41.11) can be explained by greater 
inflammatory response mounted in the body in cases of severe pancreatitis. 
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Mean CRP in the severe group was less than that noted in mild group. The peak value of CRP 
is usually attained between day 3 and 4
(60)
. The above noted variation possibly could be due 
the difference in the day they presented to our hospital. 
 
The mean amylase and lipase values did not show any correlation with severity of pancreatitis 
observed. This finding has already been supported in other literatures 
(12).
 
 
The number of days in hospital and in the   ICU (18.32 ± 20.95 days and 6.26 ± 10.39 days 
vs.  4.98 ± 2.73days and 0.08 ± 0.45 days)   were higher in the severe group when compared 
with the mild pancreatitis group, which can well be explained with the severity of the disease. 
 
In our study 41.73% had local complications. Acute fluid collection was observed in 37 %( 
47/127), pseudocyst was observed in 7.08 %( 9/127), pancreatic necrosis more than 30 % was 
observed in 5.51% (7/127) and Pancreatic abscess in 0.7% (1/127).  Mifkovic A et al reported 
similar incidence of acute fluid collections in cases with acute pancreatitis 
(61).
The incidence 
of pseudocyst were noted in about 7.08% in our study. This finding was similar to the finding 
noted by Baig et al, (8.8%) who conducted a study in eastern India in acute Pancreatitis 
(6)
. In 
our study pancreatic necrosis was found in 5.51%. . Mifkovic  A et al, reported  incidence of 
necrosis of pancreas  in 15- 25% cases with acute pancreatitis 
(61).
The low incidence in our 
study may be due to the fact that,  we have taken only necrosis more than 30 % into account 
for analysis Pancreatic abscess was observed in 0.7% of total cases. Beger et al in 1998, 
observed in his study the occurrence of pancreatic abscess in 2-10 % of cases of acute 
pancreatitis. The less number of pancreatic abscesses in our study could be due to use of 
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higher generation antibiotics at the onset of infection and earlier surgical intervention in 
necrotic pancreas 
(62).
 
 
Organ failure was noted in 30/127 (24.04%). Magda A Shaheen et al, in his study also 
reported similar percentage of acute pancreatitis patients having organ failure 
(62)
.In our study 
population   pulmonary insufficiency was the most common organ failure followed by shock, 
renal failure and Gastrointestinal bleed. Ai-Jun Zhu et al, also observed similar pattern of 
organ failure in his study, respiratory failure being the most commonest 
(57).
 
 
17/127 had blood culture positive for infectious agents, of whom 08 had Klebsiella, 07 had  
E Coli, and 01 each had Acinetobacter, Enterococci and Candida. Ascitic culture grew 
Klebsiella in three and Ecoli in one. Urine had grown Ecoli, Klebsiella and Enterococci in 1 
each patients. Sputum grew Klebsiella in two patients.  Pramod Kumar Garg et al in 2001, in 
his study conducted in North India observed Ecoli as the most common organism followed by 
pseudomonas as cause for sepsis in acute pancreatitis and blood was the most common 
specimen from which bacteria was isolated .The difference in microbial pattern could well be 
due to difference in the microbial pattern of infection in different institutions as well as 
change in protocol of management in the use of antibiotics throughout these years 
(64).
 
 
Of all the 127 patients 49 patients (38.58%) required Nasojejunal feeds and 3/127 (2.36%) 
required Total Parenteral Nutrition for improving their nutrition during their course of 
disease. 
 
6/127(4.72%) required surgery during their admission period .In one study from north India 
,Babu  R Y  et al, noted requirement of surgery/ radiological drainage   in 80 percentage of 
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severe pancreatitis on continued follow up 
(65).
 The low percentage in our study could be due 
to the cross sectional study nature and  many of these patients may requires  a radiological / 
surgical intervention in their long term follow up visits. 
 
10.2 % of the toal study patients died during the course of their disease. All the patients who 
died were having severe pancreatitis .So mortality was observed in 19.6% (13/66) of acute 
severe pancreatitis . Neoptolemos JP et al and Rau B et al, in two separate studies also 
observe red 15-30% mortality associated with severe acute pancreatitis 
(66, 67)
.  
 
In our study it was observed that 52% (66/127) had severe pancreatitis and rest 48% had mild 
disease. This was against the general observation of 85% mild disease and 15 % severe 
disease 
(1).
This can be explained by the fact that our institution being a main  tertiary care 
centre in southern India ,more severe cases were referred from different parts of country to 
this institution. 
 
Alcohol was the most common aetiological factor (48.8% -62/127), second being biliary  
24% (30 /127) followed by idiopathic (20%),Post ERCP (6.29%)  and  drugs (1/127) for 
which Neomercazole was found to be the culprit .This was similar to the observation found  
by Sarfaraz Jalil Baig, et al, from eastern India  in which alcohol was the most common 
aetiology (35.5%) followed by 22.2% due to gallstones, 20% due to trauma, 13.3% due to 
idiopathic causes, and 8.8% following ERCP 
(14)
. 
 
Out of the total 127 patients 15/127(11.8%) had recurrent episodes of pancreatitis of which11 
were mild and 4 were severe. This was similar to the observation noted by Peter A Banks et 
al, in which 10.9% of the study population were found to have recurrent acute Pancreatitis 
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(68)
. Of all the causes of recurrent acute pancreatitis idiopathic group stands first. This was 
followed by biliary, alcohol and posts ERCP causes. In the severe group the aetiology behind 
recurrent acute pancreatitis were shared one each between idiopathic , biliary , alcoholic and 
post ERCP.In one previous study from our institution Sajith K G et al , reported biliary 
disease (37%) as the most common cause followed by pancreatic divisum (8.5%) and 
alcohol (6.4%). Multiple aetiologies were seen in 7% of cases, and no cause was found in 
32.4% in that study. The difference in the observation can be explained by the large 
population of recurrent acute pancreatitis (188 Patients )in the previous study when compared 
with less number of recurrent acute pancreatitis  (15 patients ) in our present study. 
The unpooled genetic data analysis of   rs2227956  and  rs1008438 gene polymorphism 
against different  outcomes  assessed in this study (such as organ failure, need for  ICU 
admission , pulmonary insufficiency ,pressure support ,need for surgery, mortality  , and 
severity of disease ) were not showing a significant statistical correlation. Since the numbers 
of patients in the homozygous CC groups were too small to make any conclusion, we further 
done a pooled genetic analysis (CC/CT vs.  TT and AA/AC vs. CC) for the above variables.  
The pooled genetic data analysis of rs 2227956 showed significant correlation between 
presence of homozygous TT genetic polymorphism and need for pressure support (P = 
0.044). Also some of the other variables like overall organ failure, pulmonary insufficiency, 
and over all severe pancreatitis groups showed a trend towards correlation with presence of 
homozygous TT gene in rs2227956 genetic polymorphism group. This finding points towards 
a possibility that those who are having homozygous TT allele with rs2227956 genetic 
polymorphism are at risk for a severe course disease if they have an episode of acute 
pancreatitis. The reason why all other parameters did not showed a statistically significant 
trend could be due to low power of the study because of less number of patients included in 
this study. Since this study was based on a previous study, which analysed the role of HSP 
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gene 70 polymorphism in severity of diabetic foot ulcer and outcomes in surgical treatment 
(40)
, it might have not helped in calculating an accurate sample size for testing the same 
polymorphism in acute pancreatitis. The previous study on assessment of the role of HSP 
gene 70 polymorphism in severity of diabetic foot ulcer and outcomes in surgical treatment 
was selected as the basis for this present study  because that  was conducted  in the same 
institution in the same back ground of population so as the genetic makeup of the population 
will not differ much. 
 
The pooled genetic data distribution of rs1008438 gene polymorphism in patients with the 
above mentioned variables also did not reveal any statistical correlation.  
 
The unpooled genetic data analysis in patients with rs1061581 and rs 1043618 gene   
polymorphism to correlate with the same variables mentioned in the above analysis did not 
reveal any statistical significance. 
 
Further the pooled genetic data of all the four single nucleotide polymorphisms (rs 2227956, 
rs1008438, rs1061581 and rs 1043618)     were analysed to see for any correlation with the 
number of days hospitalized   as well as with the number of days spent in ICU.  In the rs 
2227956 gene polymorphism group, the mean number of days stayed in hospital in CC/CT 
pooled groups and TT genotype groups were 8.16±8.564 and 12.06±16.00 respectively and 
the corresponding numbers of days stayed in ICU were 1.42±3.374 and 3.90±9.142 days 
respectively. The number of days stayed in ICU were found to be more and was found to 
have statistically significant in the group   with homozygous TT in those with  rs 2227956 
gene polymorphism (P value = 0.031) than  those with CC  or  CT gene polymorphism. This 
again correlates with the above observed data. 
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The pooled genetic data analysis for the other polymorphisms such as rs1008438, rs1061581 
and rs 1043618 did not showed any statistically significant correlation with the number of 
hospital days and days spent in ICU. 
  
Perhaps further studies with a larger population may reveal a statistically significant 
correlation between rs 2227956 HSP gene 70 polymorphisms and severity of the disease. 
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SUMMARY 
AND 
CONCLUSIONS 
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 Alcohol was the most common cause for acute pancreatitis in this study followed by 
biliary stones  
 Male gender is affected more than females 
 Severe Acute Pancreatitis  were observed in more than half of the study population  
 Local complications were present in 41.73% of study population of which acute fluid 
collection was the commonest followed by pseudocyst, necrosis and abscess. 
 Organ failure was present in one fourth of the study population  
 Respiratory insufficiency was the most common organ failure followed by 
cardiovascular ,renal and gastrointestinal complication 
 Klebsiella was the most common organism grown in patient with infection 
 The mortality in acute severe pancreatitis was 20 %. 
 One tenth of the total population studied had recurrent acute pancreatitis with   biliary 
stones as the most common aetiology after excluding the idiopathic group. 
 Homozygous TT rs 2227956 gene polymorphism showed statistically significant 
correlation with the need for pressure support ,length of ICU stay and it also showed a 
trend  towards significance for overall organ failure, overall severity of the disease 
and pulmonary insufficiency. 
 There is a possibility that those who are having homozygous TT allele with rs2227956 
genetic polymorphism are at risk for a severe course of disease if they have an episode 
of acute pancreatitis. 
 Further studies with a larger population may reveal a statistically significant 
correlation between rs 2227956 HSP gene 70 polymorphisms and severity in acute 
pancreatitis disease. 
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Informed Consent document PATIENT’S INFORMATION 
 
I understand that Dr. UNNIKRISHNAN.L.S.  is doing a study to identify the parameters   
that help in correlating the severity of acute pancreatitis and gene polymorphism.  The 
study involves being interviewed (about the disease) and noting the results of test reports 
that are being done by the treating doctors for clinical care. A sample of blood will be 
taken to find out if there is a particular kind of gene pattern that may predispose me (or 
my patient) to severe illness. The results of the test done in connection with the study may 
not directly benefit me.  They are likely to indirectly benefit other patients with the 
disease. 
 
I understand that my withdrawal from the study at any time will not affect the treatment 
being given. 
 
Study Title:     Study Number: 
Subject‟s Initials: _________    Subject‟s Name: ________ 
Date of Birth / Age:_______   Please initial box  
(Subject) 
 
(i) I confirm that I have read and understood the information sheet dated _________ for 
the above study and have had the opportunity to ask questions. [ ] 
(ii) I understand that my participation in the study is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my medical care or legal rights 
being affected. [ ] 
(iii) I understand that the Sponsor of the clinical trial, others working on the Sponsor‟s 
behalf, the Ethics Committee and the regulatory authorities will not need my permission  
to look at my health records both in respect of the current study and any further research 
that may be conducted in relation to it, even if I withdraw from the trial. I agree to this 
access. However, I understand that my identity will not be revealed in any information 
released to third parties or published. [ ] 
(iv) I agree not to restrict the use of any data or results that arise from this study provided 
such a use is only for scientific purpose(s) [ ] 
(v) I agree to take part in the above study. [ ] 
 
Signature (or Thumb impression) of the Subject/Legally Acceptable 
Representative:_____________  Date: _____/_____/______ 
Signatory‟s Name: _________________________________ 
 
Signature of the Investigator: ________________________ 
Date: _____/_____/______ 
Study Investigator‟s Name: _________________________ 
 
Signature of the Witness: ___________________________ 
Date:_____/_____/_______ 
Name of the Witness: _________________________ 
 
                                                      
 
 
 
80 
 
                                         PROFORMA                              Study no. 
 
Demographic data 
Name  :       
Age (years) :  
Sex   : Male / Female      
Hosp Num :   
Occupation : 
Address : 
 
Phone No : 
 
Recruitment data 
  Outpatient follow-up  /  Emergency Service  /  Admitted to ward 
 
Clinical data 
Abdominal pain: Duration:  
   Location: Epigastrium  / Generalized  /  Other 
Precipitating factors: Alcohol binge  /  Fatty food  /  Trauma  /  Others  /  Nil 
Vomiting:  Yes  / No 
Breathlessness: Yes  /  No 
Decreased urine output: Yes  /  No 
GI bleed:  Yes  /  No 
Fever:   Yes  /  No 
Others:   
Alcohol consumption: Nil  /  Social  /  Alcoholic    Qty    Type      Yrs 
 
Admission characteristics: 
Pulse                    BP             Temp                 Respiratory rate 
 
Simplified Glasgow scoring system (Score >2 in first 48 h = severe) 
 
Variable  Absent  Present 
Age >55 yrs   
PaO2 <60 mm Hg   
WBC >15,000/mm
3
   
Ca2+ (uncorr.) <8 mg%   
LDH>600 IU/L   
Glucose  >180 mg%   
Urea >45 mg%   
Albumin <3.2 g%   
TOTAL SCORE  
 
CRP  : 
S. Amylase  : 
S. Lipase  : 
PCV  : 
81 
 
Chest X Ray:  Normal Y / N  (if abnormal, at admission or later?) 
   Effusion Y / N 
   ARDS  Y / N 
Ultrasonography:  
Gallstones / Biliary dilatation / Pancreatic oedema / Fluid collection / Other 
 
CECT:  Done / Not done  CTSI (if available: 
 
Findings: 
 
 
Hospital course:  
Admitted during study  /  Discharged from A&E  /  Date obtained from records  
(now seen in OPD) 
 
I) Local complication:    Acute fluid collection 
                                         Pseudocyst 
                                         Abscess   
 
II) Organ Failure:                  Yes   /   No 
CVS              Systolic BP <90 mm Hg 
Respiratory    PaO2 <60 mmHg 
Renal             Creatinine >2 mg/dl after rehydration 
Haematologic GI Bleed >500cc in 24 hours  
CNS  
Liver  
 
III) Sepsis: 
 
Hospital stay:       ____ days   DOA   DOD 
 
ICU stay:     No   /  Yes     If yes,    ____ days 
                    
Interventions:       
     Pressor support needed  N   /   Y  
      Ventilatory support needed  N   /   Y    (non-invasive / invasive) 
       Dialysis support needed  N   /   Y 
 
Feeding: TPN   /   NJ   /   Oral 
Surgery:     Yes   /   No 
Outcome: Dead    /   Alive 
 
Final Diagnosis: Acute pancreatitis (first attack) 
Aetiology : 
Severity : 
 
 
Sl.no Name Age Sex Hosp:No. Occupationstate /country recruitment data
1 Ramjee Ganju 58 Male 876490d Manual LabourJharkand admitted
2 Bachchi Devi 66 Female 592054d H wife Bihar admitted
3 Dhayalan 54 Male 415357d Private job Tamilnadu admitted
4 Reddyappa 29 Male 887953d Manual LabourAndrapradeshadmitted
5 Ramdulalsingh 41 Male 869357d Private job Jharkand admitted
6 Muzaffar 30 Male 896255d Manual LabourMP admitted
7 Topivalli 59 Male 895563d Teacher Andrapradeshadmitted
8 Duraiswamy 52 Male 891735 Business Tamilnadu admitted
9 Bhuvaneswari 26 Female 637790d H wife Tamilnadu admitted
10 Madhivani 25 Female 266515c H wife Tamilnadu admitted
11 Adhir chandra saha43 Male 020376c Business assam admitted
12 Saravanan 30 Male 901120d Driver Tamilnadu admitted
13 Lognathan 48 Male 901250 councillor Tamilnadu admitted
14 Thavamani 42 Male 906534d farmer Tamilnadu admitted
15 Muniswamy 33 Male 901446d Manual LabourTamilnadu admitted
16 kumar 42 Male 099263b police Tamilnadu admitted
17 Rajendran 54 Male 901520d farmer Tamilnadu admitted
18 Vadivel 26 Male 908578d Manual LabourTamilnadu admitted
19 MarydoraBlah 63 Female 445196b Teacher meghalaya admitted
20 Kumaresan 38 Male 908990d Manual LabourTamilnadu admitted
21 Melak pradhan 37 Male 917992d Manual Labourrissa admitted
22 Govindaswamy 36 Male 915139d Manual LabourTamilnadu admitted
23 Anasuyadas 47 Female 917714d H wife w Bengal admitted
24 Nagaraju 37 Male 923104D Manual LabourAndrapradeshadmitted
25 Subramani 76 Male 510716B Manual LabourTamilnadu admitted
26 wrick choudhary 27 Male 932496D Business w Bengal admitted
27 Solomon 30 Male 846266D Business Tamilnadu admitted
28 Gitachanda 41 Female 814079c H wife assam admitted
29 Dasari lakshmi Narayana44 Female 927653d Business Andrapradeshadmitted
30 Sahidur Rahman G25 Male 842734d Business w Bengal admitted
31 Kabita karmakar48 Female 571973c H wife w Bengal admitted
32 Srinivasulu 44 Male 826192d Manual LabourAndrapradeshadmitted
33 Balasubramaniyam23 Male 927872d student Tamilnadu admitted
34 Muniyamma 55 Female 937614d H wife Tamilnadu admitted
35 murukeshan 47 Male 554522b councillor Tamilnadu admitted
36 Asmathunisa 49 Female 937889d H wife Tamilnadu admitted
37 Ravi 23 Male 942471d Manual LabourTamilnadu admitted
38 krishnareddy 44 Male 942223d Manual LabourAndrapradeshadmitted
39 Swarup 22 Male 942694d student Tamilnadu admitted
40 Giridar 44 Male 964647d Manual LabourAndrapradeshadmitted
41 parimala 42 Female 962770D H wife Tamilnadu admitted
42 Elumalai 61 Male 968134D Driver Tamilnadu admitted
43 Muskan Sawlavi 26 Female 982723D Teacher UP admitted
44 Sakunthala 49 Female 284080D H Wife Tamilnadu admitted
45 Anatharaj 28 Male 098786C Manual LabourAndrapradeshadmitted
46 Sangeetha 15 Female 845264D student Andrapradeshadmitted
47 Pankaj Kumar Shattacharjee35 Male 970753D Manual Laboursikkim admitted
48 Joseph 38 Male 983611D Manual LabourTamilnadu admitted
49 Ranjith kumar 24 Male 261056D Manual LabourTamilnadu admitted
50 Mohammed 53 Male 491413D Manual LabourTamilnadu admitted
51 Mani 57 Male 910038D clerk Tamilnadu admitted
52 Ravindrakumar Yadav32 Male 904013D Business Chattisgarh admitted
53 Manogaran 31 Male 992588D Engineer Tamilnadu admitted
54 Govindaraj 30 Male 992935D Business Tamilnadu admitted
55 Rangaraj 36 Male 995347d Business Tamilnadu admitted
56 Thullasamma 25 Female 002237f H Wife Andrapradeshadmitted
57 Srinivasan 36 Male 005245f shop keeperAndrapradeshadmitted
58 Dhachinamurthi 45 Male 008123f farmer Tamilnadu admitted
59 Yania Haji 60 Female 003936f H Wife arunachal Pradeshadmitted
60 Raja 39 Male 046151f farmer Tamilnadu admitted
61 Rajesh 27 Male 111409D student Andrapradeshadmitted
62 Munisamy 35 Male 032267f Manual LabourTamilnadu admitted
63 Irudayamary 60 Female 061510f H Wife Tamilnadu admitted
64 Prasad 35 Male 068700f Manual LabourAndrapradeshadmitted
65 Sam 30 Male 750089d Business Tamilnadu admitted
66 kothandan 51 Male 069561f Manual LabourTamilnadu admitted
67 Dileepkrishna 29 Male 071884f Manual LabourAndrapradeshadmitted
68 Debabradadas 48 Male 331039b Business w Bengal admitted
69 Meeta roy choudhury46 Female 823463d H Wife Jharkand admitted
70 kumaravel 49 Male 950439b Manual LabourTamilnadu admitted
71 Sathishkumar 35 Male 998876b student Tamilnadu admitted
72 Sounderajan 47 Male 077436f Manual LabourTamilnadu admitted
73 Joyceevasantharani50 Female 642516b H Wife Tamilnadu admitted
74 Jeyadurga 15 Female 089408f student Tamilnadu admitted
75 venkatesan 31 Male 089833f shop keeperTamilnadu admitted
76 Asparabarua 58 Female 076149f H Wife bangladesh admitted
77 Murugesan 50 Male 944145f Manual LabourTamilnadu admitted
78 Ramanaiah 58 Male 098588f Manual LabourTamilnadu admitted
79 Bhavani 22 Female 910912d H Wife Tamilnadu admitted
80 Sarguna 55 Female 098281f H Wife Tamilnadu admitted
81 Goaspeer 27 Male 094919f Manual LabourAndrapradeshadmitted
82 Sivappa 41 Male 110120f Manual LabourAndrapradeshadmitted
83 Ataullah khan 27 Male 113971f Manual LabourAndrapradeshadmitted
84 Karthikeyan 34 Male 107220f Manual LabourTamilnadu admitted
85 Murthi 39 Male 098623f Manual LabourTamilnadu admitted
86 Muniratnamreddy64 Male 116317f Manual LabourAndrapradeshadmitted
87 Malliga 56 Female 112687f H Wife Tamilnadu admitted
88 Parvathi ammal 70 Female 350047c H Wife Tamilnadu admitted
89 Jalapati 37 Male 058754f Business Tamilnadu admitted
90 Ekambram 63 Male 373384a Manual LabourTamilnadu admitted
91 Jayaganesh 22 Male 473681c Manual LabourTamilnadu admitted
92 Manoharan 39 Male 094808b Manual LabourTamilnadu admitted
93 Jithinroy 21 Male 124338f student kerala admitted
94 Partheeban 32 Male 993654b Manual LabourTamilnadu admitted
95 Sudhakar 28 Male 937536d Business Tamilnadu admitted
96 Kavadiguravaiah33 Male 139079f Manual LabourAndrapradeshadmitted
97 Manimaran 43 Male 133396f Manual LabourTamilnadu admitted
98 Mahalingam 34 Male 914781d Manual LabourTamilnadu admitted
99 Janakiramanaidu30 Male 136131f Manual LabourAndrapradeshadmitted
100 Firoza khation 47 Female 145536f H Wife Jharkand admitted
101 Rajendran 57 Male 430958d Manual LabourTamilnadu emergency service
102 Dilipkumar 31 Male 147134f Business w Bengal admitted
103 Vijaya 40 Female 139364f H Wife Tamilnadu admitted
104 Mahesh 29 Male 133518f Business Andrapradeshadmitted
105 Ekambaram 30 Male 130489f Business Tamilnadu admitted
106 Poongodi 34 Female 130348c H Wife Tamilnadu admitted
107 Bashirudden 62 Male 159572f Business Tamilnadu admitted
108 Sriramlu 50 Male 162220f Manual LabourAndrapradeshadmitted
109 Agayakumar 38 Male 169127f Manual LabourBihar admitted
110 Babu 31 Male 171708f Manual LabourTamilnadu admitted
111 Gopi 34 Male 174326f security guardTamilnadu admitted
112 Sreedevi 34 Female 139347f H Wife Tamilnadu admitted
113 Gousiya 18 Female 119454f student Andrapradeshadmitted
114 Muniswamy 28 Male 174438f Manual LabourAndrapradeshadmitted
115 Mahalakshmi 43 Female 001903B ANM CMC Tamilnadu admitted
116 Devit 29 Male 192884f Manual LabourTamilnadu admitted
117 Venkateshbabu 37 Male 889196d Driver Tamilnadu admitted
118 Suryakala 46 Female 849024a H Wife Tamilnadu admitted
119 Das 46 Male 198858f Driver Tamilnadu emergency service
120 Indeshwarihishra68 Male 218842f shop keeperkarnataka admitted
121 Venkatesan 25 Male 222737f Driver Tamilnadu admitted
122 Rossiah 69 Male 222410F no job Andrapradeshadmitted
123 Juyashankar 27 Male 620152d Driver Andrapradeshadmitted
124 Natraagaruvel 26 Female 543533d Business Chattisgarh admitted
125 Poongodi 35 Female 236987f H Wife Tamilnadu admitted
126 Ramakrishna reddy42 Male 234980f no job Andrapradeshadmitted
127 Venkateshbba reddy55 Male 234948f no job Andrapradeshadmitted
male 93
female 34
73.228 0 0 0 0
26.772 0 0 0 0
73.22
26.77
p.complaint ppt: factors SGSscore CRP amylase lipase PCV
pain, vomiting, fever Nil 3 154 370 296 350
pain, vomiting, fever post ERCP 2 >218 829 1957 38
pain,vomiting,dyspnoea,fever alcohol 4 >218 287 545 35
pain ,vomiting alcohol,hypertriglyceridemia 1 >218 157 396 38
pain, vomiting, dyspnoea Nil 4 >216 509 209 32
pain ,vomiting alcohol 2 77 500 861 38
pain Nil 2 171 3922 7340 40
pain post ERCP 2 100 2077 3608 21
pain ,vomiting Nil 0 11.2 1485 3502 39
pain, vomiting, dyspnoea Nil 3 218 1678 3370 61
pain,vomiting,dyspnoea,fever Nil 6 218 50 71 18
pain,vomiting,dyspneoa,fever,↓ urine alcohol 4 218 276 261 44
pain, vomiting, dyspnoea alcohol 1 218 1104 2418 35
pain, vomiting, fever Nil 0 15 261 836 29
pain ,vomiting alcohol 1 218 894 3112 45
pain ,vomiting alcohol 3 25 512 3014 57
pain ,vomiting alcohol 2 196 129 185 37
pain ,vomiting alcohol 1 218 128 246 42
pain,vomiting,dyspnoea,fever post ERCP 3 214 616 1049 37
pain,vomiting,dyspnoea,fever alcohol 5 218 1004 1228 31
pain ,vomiting Nil 1 20.2 290 247 47
pain ,vomiting alcohol 2 30.6 351 540 42
pain ,vomiting post ERCP 1 75 1825 5081 34
pain,vomiting,dyspneoa,fever,↓ urine alcohol 6 197 142 383 52
pain ,vomiting Nil 6 200 3219 18250 42
pain ,vomiting alcohol 4 197 509 271 36
pain ,vomiting alcohol 0 148 1375 2756 38
pain,vomiting,dyspnoea,fever post ERCP 1 10 679 1528 37
pain,vomiting,dyspneoa,fever,↓ urine Nil 6 218 3278 3032 50
pain ,vomiting post ERCP 0 79 486 696 42
pain ,vomiting Nil 1 6 4134 14280 38
pain ,vomiting Nil 0 47 1876 5258 37
pain ,vomiting Nil 3 197 23 443 44
pain, vomiting, dyspnoea Nil 2 185 1810 2330 27
pain,vomiting,dyspnoea,fever alcohol 1 116 479 1311 45
pain, vomiting, fever Nil 1 157 953 1783 36
pain,vomiting,dyspnoea,fever alcohol 3 197 151 255 40
pain,vomiting,dyspnoea,fever alcohol 5 197 900 526 40
pain ,vomiting Nil 0 77 2639 7248 42
pain ,vomiting alcohol 1 82 261 815 39
pain,vomiting,dyspnoea,fever Nil 4 197 167 693 36
Pain alcohol 4 197 263 771 47
pain Nil 0 48 1234 1549 42
pain ,vomiting Nil 1 10.8 225 418 31
pain ,vomiting alcohol 0 85 288 587 45
pain ,vomiting Nil 0 2.97 889 2368 360
pain ,vomiting nil 0 7.2 80, 215 67 41
pain ,vomiting Nil 1 37.5 180 564 45
pain Nil 0 163 1034 3796 45
pain,vomiting,dyspnoea,fever Nil 2 178 4490 9362 46
pain ,vomiting Nil 1 57.2 1227 1598 40
pain,vomiting,dyspnoea,fever Nil 4 40 1513 2487 46
pain ,vomiting alcohol 4 133 1260 1608 62
pain, vomiting, fever alcohol 3 173 530 626 60
pain ,vomiting alcohol 2 129 382 462 36
pain, vomiting, fever Nil 5 189 3000 2815 30
pain,vomiting,dyspnoea,fever alcohol 5 153 296 1520 61
pain,vomiting,dyspnoea,fever alcohol 5 80 1897 1616 52
pain, Fever Nil 4 88.2 962 2161 43
pain ,vomiting alcohol 2 190 863 2006 53
pain ,vomiting Nil 2 21.4 960 1580 48
pain ,vomiting alcohol 6 184 1204 2061 60
pain, vomiting, dyspnoea Nil 6 190 1594 4314 44
pain ,vomiting alcohol 0 49 1034 910 43
pain, vomiting, fever alcohol 2 186 152 163 44
pain ,vomiting Nil 0 37.9 1034 864 43
pain, vomiting, dyspnoea alcohol 1 111 85 92 44
pain ,vomiting alcohol 0 37.9 1712 5204 46
pain ,vomiting fatty food 1 95.1 297 780 27
pain ,vomiting fatty food 1 130 484 1488 42
pain ,vomiting Nil 0 7190 50.192 332.88 -
pain ,vomiting alcohol 0 91.2 930 2064 45
pain ,vomiting Nil 1 52 603 3050 38
pain ,vomiting Nil 0 846 2698 4200 32
pain, vomiting, dyspnoea alcohol 1 122 572 1776 42
pain, vomiting, dyspnoea Nil 4 170 203 279 37
pain ,vomiting fatty food 2 107 3303 6678 57
pain ,vomiting alcohol 3 120 414 814 42
pain ,vomiting fatty food 0 36.8 2029 2914 40
pain ,vomiting Nil 1 132 1162 1944 46
pain ,vomiting alcohol 0 190 711 1373 40
pain, vomiting, dyspnoea alcohol 3 136 1110 3494 42
pain ,vomiting Nil 1 190 1104 1601 43
pain ,vomiting alcohol 0 46 198 234 40
pain ,vomiting alcohol 0 190 241 381 48
pain, vomiting, dyspnoea Nil 6 190 999 864 52
pain ,vomiting fatty food 0 190 2464 949 42
pain ,vomiting Nil 5 190 1651 2954 48
pain ,vomiting Nil 0 34.7 2663 2950 54
pain ,vomiting alcohol 1 21.6 3419 6550 48
pain, vomiting, dyspnoea alcohol 4 42 494 567 48
pain ,vomiting Nil 1 116 144 170 42
pain ,vomiting Nil 0 129 427 668 44
pain, vomiting, dyspnoea alcohol 5 190 1167 1394 48
pain ,vomiting alcohol 1 112 967 1118 40
pain ,vomiting alcohol 4 150 398 776 48
pain ,vomiting alcohol 0 152 368 346 41
pain ,vomiting alcohol 1 11 226 331 45
pain ,vomiting alcohol 4 190 1453 2018 44
pain ,vomiting fatty food 1 21.4 92 252 42
pain ,vomiting alcohol 1 53.2 243 549 48
pain,vomiting,dyspnoea,fever alcohol 5 106 236 843 48
pain, vomiting, dyspnoea Nil 1 190 1766 3667 46
pain ,vomiting alcohol 1 140 550 272 53
pain ,vomiting alcohol 0 61 1017 1172 42
pain ,vomiting alcohol 1 59 426 439 29
pain ,vomiting Nil 2 31 927 937 42
pain ,vomiting alcohol 1 95.1 583 392 45
pain ,vomiting alcohol 1 42 429 651 30
pain ,vomiting alcohol 1 101 637 1321 60
pain, vomiting, dyspnoea alcohol 4 140 582 1620 45
pain ,vomiting Nil 0 114 255 1314 38
pain ,vomiting Nil 1 100 445 1267 48
pain, vomiting, dyspnoea alcohol 5 190 587 996 54
Pain Nil 0 78.5 211 605 33
pain,vomiting,dyspnoea,fever Nil 2 184 336 691 41
pain Nil 0 163 496 1150 53
pain Nil 0 79.2 887 2512 30
pain, vomiting, dyspnoea Nil 0 9.44 237 227 38
pain Nil 2 12.6 1050 1090 39
pain, vomiting, dyspnoea alcohol 3 190 478 1974 62
pain, vomiting, dyspnoea Nil 3 127 322 587 40
pain ,vomiting alcohol 0 102 675 3071 45
pain ,vomiting Nil 0 80 4522 5197 40
pain ,vomiting Nil 0 100 239 400 40
pain ,vomiting Nil 4 122 239 237 34
pain ,vomiting alcohol 0 95.3 153 244 40
0
0
CHEST XRAY USG CT
left sided effusion not done bulkypancreas,pseudocyst
bilateral Effusion normal bulkypancreas,necrosis>30%,ascites
bilateral Effusion Pancreaticedema bulkypancreas , collections,splenic vein thrombosis
Normal normal bulky pancreas necrosishead <30%
bilateral Effusion collections bulky pancreas,collections,pseudocyst
left sided effusion Pancreaticedema,collections pancreatic edema collections , necrosis >30%
Normal cholelithiasis not done
Normal pancreatic edema not done
Normal gallstones ,pancreatic edema not done
bilateral Effusion pancreatic edema ,fluidcollect pancreatic edema collections
left sided effusion normal pancreaticedema,fluid collections
left sided effusion normal ascites,pancreatic edema
bilateral Effusion pancreatic edema Pancreatic edema,fluid collection
Normal cholelithiasis not done
Normal pancreaticedema not done
left sided effusion pan edema ,collections not done
bilateral Effusion normal gall stones, pan edema collections
left sided effusion pan edema not done
bilateral Effusion pancretic edema,collections panedema,collection,bilateral pleu effusion
left sided effusion panedema,collections >30%necrosis,collections
Normal pancreatic edema,collection pseudocyst 
Normal pan edema not done
Normal normal not done
Normal fluid collection fluid collection
bilateraleffusion, ARDS not done bulkypan,nec <30%,CTSI=6
bilateral Effusion not done bulky pancreas ,ascites
Normal pacreatic edema not done
Normal normal not done
bilateral Effusion pancr edema ,collection bulky pancreas,collections,
Normal normal not done
Normal gallstones ,pancreatic edema not done
Normal gallstones   not done
Normal pancreati edema,Gb sludge not done
bilateral Effusion pan edema,gall stone, collectioncholelithiasi,pan edema,collection, ascites
left sided effusion cholelithiasis not done
Normal pancredema not done
left sided effusion pancr edema ,collection pan edema ,collection
left sided effusion pancredema,collection pan edema,necrosis>30%,collection
Normal biliary dilatation,panedema not done
Normal normal not done
Normal not done pancreatic edema
bilateral effusion bulky pancreas bulky pancreas, splenic vein thrombosis
Normal pancreatic edema not done
Normal pancreatic edema not done
Normal pancreatic edema not done
Normal pan edema not done
Normal fluid collection pseudocyst,necrosis<30%, splenic vein thrombosis
Normal not done not done
Normal pancreatic edema not done
bilateraleffusion, ARDS gallstones not done
Normal pancreatic edema pancreatic edema
Normal pancreatic edema pancreatic edema,fluid collection, gross ascites, 
Normal pancreatic edema necrosis >30 %, pancreatic edema, fluid collection
Normal not done pancreatic edema, fluid collection
left sided effusion pancreatic edema fluid collectionpancreatic edema, fluid collection,necrosis<30% 
bilateral Effusion fluid collection fluid collection, necrosis >30 %, gross ascites
left sided effusion normal pancreatic edema, fluid collection,splenic vein thrombosis
bilateral Effusion pancreatic edema pancreatic edema, fluid collection,splenic vein thrombosis
left sided effusion pancreatic edema pancreatic edema
bilateral Effusion pancreatic edema pancreatic edema, fluid collection, necrosis<30% ,gross ascites
left sided effusion pancreatic edema, fluid collectionbiliary dilatation, gross ascites
bilateral Effusion gall stone gall stone
bilateral Effusion pancreatic edema pancreatic edema, fluid collection, necrosis <30 %
Normal Gifally fever pan odena
bilateral Effusion not done pancreatic edema
Normal pancreatic edema not done
bilateral Effusion panedema,collections, GB sludgernot done
Normal pancreatic edema not done
Normal bilateral pancreatic edema
Normal not done pancreatic edema
Normal pancreatic edema pancreatic edema
left sided effusion normal pancreatic edema, fluid collection, necrosis <30 %
Normal biliary dilatation biliary dilatation
Normal bulky pancreas not done
left sided effusion normal pan edema,nec<30%,plenic vein thrombosis,
Normal pancreatic edema pancreatic edema, 
Normal pancreatic edema not done
Normal normal fluid collection
Normal gallstones Biliary dil not done
Normal bulky pancreasGall stones not done
Normal bulky pancreas not done
left sided effusion not done pancreatic edema,splenic vein thrombosis
Normal bulky pancreas not done
Normal bulky pancreas not done
Normal bulky pancreas not done
left sided effusion pancreatic edema  ,fluid collectionpa creatic edema,fluid collection, gross ascites
Normal normal not done
left sided effusion biliary dilatation pancreatic edema, fluid collection, splenic vein thrombosis
Normal gall stones gall stone
Normal normal not done
bilateral Effusion pancreatic edema  ,fluid collectionpa creatic edema, fluid collection,pseudocyst
Normal cholelithiasis,biliary dilatation gall stone,biliary dilatation
Normal not done pancreatic edema
bilateral Effusion pancreatic edema pan edema ,collection,ascites
Normal panereatic edema not done
left sided effusion not done pancreatic edema, fluid collection
Normal panereatic edema not done
Normal normal not done
bilateral Effusion not done pancreatic edema, fluid collection,necrosi>30%
Normal pancreatic edema pancreatic edema
Normal pancreatic edema not done
bilateral Effusion pancreatic edema pancreatic edema, fluid collection,ascites
bilateral Effusion not done pancreatic edema,fluid collection, gross ascites, splenic vein thrombosis
Normal not done pancreatic edema, fluid collection
Normal biliary dilatation not done
Normal gall stones,biliary dilatation not done
Normal normal not done
Normal normal not done
Normal normal pancreatic edema
bilateral Effusion normal pancreatic edema, necrosis >30 %
left sided effusion not done pancreatic edema, necrosis<30 %
Normal biliary dilatation,pancreatic edemanot done
bilateral Effusion gallstones,pancreatic edema, fluid collectiongallst n s,pancreatic edema, psudocyst
bilateral Effusion pancreatic edema, fluid collectionnot done
Normal gallstones not done
left sided effusion nil pancreatic edema, necrosis<30 %
Normal gallstones not done
Normal other paner-edema
Normal pancreatic oedema not done
Normal other paner-edema
Normal pancreatic oedema pancreatic oedema, collection-peripancreata, splenceveinthromboris
Normal pancreatic oedema, fluid collectionnot done
Normal pancreatic oedema, fluid collectionnot done
Normal other paner-edema
Normal normal paner-edema
Normal pancreatic oedema, fluid collectionpan edemo, resipanereelu collectear
Normal pancreatic oedema not done
local comp org failure sepsis bacteremia H:stay icu adm icu days pr supp vent:spp
pseudocyst no no no 17 no 0 no no
acute fluid collection no no no 11 yes 5 no no
acute fluid collection resp,renal no no 17 yes 3 no no
no no no no 3 no 0 no no
acute fluid collection, pseudocystresp no ecoli,pan drain 89 yes 20 no yes,invasive
acute fluid collection no no no 13 no 0 no no
no no no no 3 no 0 no no
no no no no 5 no 0 no no
no no no no 3 no 0 no no
acute fluid collection resp no no 13 no 0 no no
acute fluid collection resp,renal,cvsyes NFGNB-Blood 12 yes 12 yes yes,invasive
acute fluid collection resp,renal,cvsno no 16 yes 3 yes yes,invasive
acute fluid collection no no no 8 yes 3 no no
no no no no 7 no 0 no no
no no no no 6 no 0 no no
acute fluid collection no no no 5 yes 2 no no
acute fluid collection no yes NFGNBBlood 6 yes 2 no no
no no no no 4 no 0 no no
acute fluid collection,abscesscvs yes urine-ecoli 42 yes 10 yes no
acute fluid collection resp no no 17 yes 1 no no
pseudocyst no no no 8 no 0 no no
no no no no 2 no 0 no no
no no no no 7 no 0 no no
acute fluid collection cvs, resp yes candida-Blood 37 yes 15 yes yes,invasive
no cvs, resp yes blod -Ecoli 4 yes 4 yes yes,invasive
acute fluid collection resp no no 7 yes 4 no no
no no no no 5 no 0 no no
no no no no 9 no 0 no no
acute fluid collection resp,renal, cvsye blood -klebsiella 89 yes 30 yes yes,invasive
no no no no 8 no 0 no no
no no no no 5 no 0 no no
no no no no 5 no 0 no no
no no no no 7 no 0 no no
acute fluid collection no yes ascites-klebsielal 9 yes 3 no no
no no no no 8 yes 3 no no
no no no no 4 yes 2 no no
acute fluid collection, pseudocystno yes blood -enterococci 8 yes 4 no no
acute fluid collection resp yes blood,ascites-Ecoli 20 yes 7 no yes,invasive
no no no no 6 no 0 no no
no no no no 4 no 0 no no
no no no no 3 no 0 no no
no cvs, resp no no 2 no 0 yes no
no no no no 3 no 0 no no
no no no no 5 no 0 no no
no no no no 4 no 0 no no
no no no no 3 no 0 no no
pseudocyst no no no 4 no 0 no no
no no no no 3 no 0 no no
no no no no 4 no 0 no no
no cvs, resp yes no 61 yes 61 yes yes,invasive
no no no no 4 no 0 no no
acute fluid collection, pseudocystcvs, resp, gi bleedyes Ascites-klebsiella, entrococcus22 yes 13 yes no
acute fluid collection no no no 30 yes 15 no no
acute fluid collection no no Ascites-klebsiella, entrococcus16 n 0 no no
acute fluid collection no no no 7 no 0 no no
acute fluid collection no no urine-klebsiella 20 yes 5 no no
acute fluid collection resp no no 16 yes 10 no yes,invasive
acute fluid collection no yes blood-ecoli 34 yes 10 no no
no cvs no no 7 yes 3 yes no
acute fluid collection no no no 10 no 0 no no
acute fluid collection no no no 18 yes 3 no no
acute fluid collection resp,renal,cvsyes yes 58 yes 40 yes yes,invasive
acute fluid collection no no no 11 yes 3 no no
no no no no 6 no 0 no no
no no no no 4 no 0 no no
no no no no 5 no 0 no no
no no no no 5 no 0 no no
no no no no 3 no 0 no no
no no no no 8 no 0 no no
no no no no 5 no 0 no no
no no no no 5 no 0 no no
acute fluid collection no no no 6 no 0 no no
no no no no 5 no 0 no no
no no no no 3 no 0 no no
no no no urine enterococcus 16 no 0 no no
acute fluid collection yes blood cultureNFGNB positive24 yes 5 no no
no no no no 6 no 0 no no
no no yes blood ecoli 10 no 0 no no
no no no no 8 no 0 no no
no no no no 7 no 0 no no
no no no no 7 no 0 no no
no cvs, resp,renalo no 3 no 0 yes yes,invasive
no no no no 2 no 0 no no
no no no no 4 no 0 no no
no no no no 2 no 0 no no
acute fluid collection no no no 11 no 0 no no
no no no no 6 no 0 no no
acute fluid collection no no no 11 no 0 no no
no no no bloodecoli 4 no 0 no no
no no no no 2 no 0 no no
acute fluid collection, pseudocystno no no 6 no 0 no no
no no no blood ecoli 11 no 0 no no
no no no no 3 no 0 no no
acute fluid collection cvs, resp,renalyes blood klebsiella 43 yes 18 yes yes,invasive
no no no no 1 no 0 no no
acute fluid collection no yes blood staph 11 no 0 no no
no no no no 5 no 0 no no
no no no no 6 no 0 no no
acute fluid collection resp yes blood ecoli 2 yes 2 no yes,invasive
no no no no 0 no 0 no no
no no no no 1 no 0 no no
acute fluid collection resp yes blood-kleb,acineto 16 yes 8 no noninvasive
acute fluid collection resp no no 18 yes 18 no no
acute fluid collection no no no 4 no 0 no no
no no no no 7 no 0 no no
no no no no 4 no 0 no no
no no no no 3 no 0 no no
no no no no 2 no 0 no no
no no no no 3 no 0 no no
acute fluid collection no no no 8 no 0 no no
no resp yes spu-ecoli,kleb,haemophilus11 yes 2 no no
no no no no 9 no 0 no no
pseudocyst no no no 7 yes 2 no no
acute fluid collection cvs, resp,renalyes blood-kleb,/spu-kleb,pseudo15 yes 15 yes no
no no no no 10 no 0 no no
pseudocyst resp,cvs yes yes 35 yes 14 yes yes,invasive
no no no no 4 no 0 no no
no no no no 8 no 0 no no
no no no no 1 no 0 no no
no no no no 14 no 0 no no
acute fluid collection resp no no 14 yes 5 no no
acute fluid collection cvs,resp no no 105 yes 15 yes yes,invasive
acute fluid collection no no no 5 no 0 no no
no no no no 4 no 0 no no
no no no no 10 no 0 no no
acute fluid collection cvs no no 19 no 12 yes noninvasive
acute fluid collection no no no 3 no 0 no no
dialysis feeding surgery out come first/recu aetiology severity
no NJ no alive first idiopathic severe
no oral no alive first post ERCP severe
no NJ no alive first alcohol severe
no oral no alive first alcohol,hypertriglyceridemia mild
no NJ yes alive first idiopathic severe
no NJ yes alive first alcohol severe
no oral no alive first biliary mild
no oral no alive first post ERCP mild
no oral no alive first biliary mild
no oral no alive first idiopathic severe
yes NJ no dead first idiopathic severe
yes NJ no alive first alcohol severe
no NJ no alive first alcohol severe
no oral no alive first biliary mild
no oral no alive first alcohol mild
no oral no alive first alcohol severe
no oral no alive first alcohol severe
no oral no alive first alcohol severe
no NJ no alive recurrentpost ERCP severe
no NJ no alive first alcohol severe
no NJ no alive first idiopathic severe
no oral no alive first alcohol mild
no oral no alive first post ERCP mild
no NJ no alive first alcohol severe
no NJ no Dama first idiopathic severe
no oral no alive first alcohol severe
no oral no alive first alcohol severe
no oral no alive first post ERCP mild
no NJ yes alive first alcohol severe
no oral no alive first post ERCP mild
no oral no alive first biliary mild
no oral no alive first biliary mild
no oral no alive first biliary severe
no oral no alive first biliary severe
no oral no alive first alcohol mild
no oral no alive first idiopathic mild
no NJ no alive first alcohol severe
no NJ yes alive first alcohol severe
no oral no alive first biliary mild
no oral no alive first alcohol mild
no TPN no dead first drug-neomercozole severe
no NJ no Dama first alcohol severe
no oral no alive first biliary mild
no oral no alive recurrent idiopathic mild
no oral no alive recurrentalcohol mild
no oral no alive recurrent idiopathic mild
no oral no alive first alcohol severe
no oral no alive first alcohol mild
no oral no alive recurrent idiopathic mild
no NJ no dead first biliary severe
no oral no alive first alcohol mild
no NJ yes dead first alcohol severe
no NJ no Dama first alcohol severe
no NJ no alive first alcohol severe
no NJ no alive first alcohol severe
no NJ no dama first biliary severe
no NJ no alive first alcohol severe
no NJ no alive first alcohol severe
no NJ no alive first post ERCP severe
no NJ no alive first alcohol severe
no NJ no alive recurrent idiopathic severe
no nj yes alive first idiopathic severe
no NJ no alive first idiopathic severe
no nj no alive first alcohol severe
no NJ no alive first idiopathic mild
no oral no alive first idiopathic mild
no oral no alive first alcohol severe
no oral no alive first alcohol severe
no oral no alive recurrentbiliary mild
no oral no alive first biliary mild
no oral no alive first idiopathic mild
no oral no alive first alcohol severe
no oral no alive first biliary severe
no oral no alive recurrent idiopathic mild
no NJ no alive first  alcohol severe
no oral no alive first post ERCP severe
no oral no alive first biliary mild
no oral no alive first alcohol severe
no oral no alive first biliary mild
no oral no alive first biliary mild
no oral no alive first alcohol mild
yes oral no dead first alcohol severe
no oral no alive recurrent idiopathic mild
no oral no alive first alcohol mild
no oral no alive first alcohol mild
no NJ no alive first idiopathic severe
no oral no alive first idiopathic mild
no NJ no alive first biliary severe
no oral no alive first biliary mild
no oral no alive first alcohol mild
no NJ no alive first alcohol severe
no NJ no alive first biliary mild
no oral no alive recurrentbiliary mild
no NJ no dead first alcohol severe
no oral no alive first alcohol mild
no NJ no alive first alcohol severe
no oral no alive first alcohol mild
no oral no alive first alcohol mild
no TPN no Dama first alcohol severe
no oral no alive first biliary mild
no oral no alive first alcohol mild
no NJ no alive recurrentalcohol severe
no NJ no Dama first idiopathic severe
no NJ no alive first alcohol severe
no NJ no alive recurrentalcohol mild
no oral no alive first biliary mild
no oral no alive first biliary mild
no oral no alive first alcohol mild
no oral no alive first idiopathic mild
no oral no alive first alcohol mild
no oral no alive first alcohol severe
no oral no alive first biliary mild
no NJ no alive recurrentbiliary severe
no TPN no Dama first alcohol severe
no oral no alive first biliary mild
no NJ no alive first alcohol severe
no oral no alive first biliary mild
no NJ no alive first idiopathic mild
no oral no alive first idiopathic mild
no NJ no alive first biliary mild
no NJ no alive first alcohol severe
yes NJ no alive first idiopathic severe
no oral no alive first alcohol severe
no oral no alive recurrentbiliary mild
no oral no alive recurrent idiopathic mild
yes NJ no alive first alcohol severe
no oral no alive first alcohol mild
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